| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.88 | 0.004 | 0.88 | Aldehyde oxidase inhibitor | 0.875 0.004 CID_785 0.872 0.004 CID_289 | ||
| 0.873 | 0.002 | 0.885 | Alcohol oxidase inhibitor | 0.885 0.002 CID_785 0.801 0.003 CID_289 | CID_785 | |
| 0.736 | 0.005 | 0.736 | 5 Hydroxytryptamine release stimulant | 0.73 0.005 CID_785 0.687 0.008 CID_289 | ||
| 0.747 | 0.018 | 0.761 | Caspase 9 stimulant | 0.749 0.018 CID_785 0.761 0.016 CID_289 | CID_289 | |
| 0.729 | 0.003 | 0.731 | Peroxidase inhibitor | 0.731 0.003 CID_785 0.73 0.003 CID_289 | CID_785 | |
| 0.702 | 0.003 | 0.702 | GABA C receptor rho-3 antagonist | 0.699 0.003 CID_785 0.667 0.004 CID_289 | ||
| 0.659 | 0.003 | 0.731 | Estrogen antagonist | 0.731 0.003 CID_785 0.383 0.005 CID_289 | CID_785 | |
| 0.658 | 0.005 | 0.69 | Superoxide dismutase inhibitor | 0.653 0.005 CID_785 0.69 0.004 CID_289 | CID_289 | |
| 0.653 | 0.003 | 0.655 | Tyrosine 3 hydroxylase inhibitor | 0.652 0.003 CID_785 0.655 0.003 CID_289 | CID_289 | |
| 0.642 | 0.003 | 0.705 | Estrogen receptor beta antagonist | 0.705 0.003 CID_785 0.387 0.004 CID_289 | CID_785 | |
| 0.627 | 0.008 | 0.627 | 5 Hydroxytryptamine release inhibitor | 0.627 0.008 CID_785 0.584 0.013 CID_289 | ||
| 0.61 | 0.004 | 0.656 | Alpha-N-acetylglucosaminidase inhibitor | 0.656 0.003 CID_785 0.61 0.004 CID_289 | CID_785 | |
| 0.607 | 0.008 | 0.738 | Free radical scavenger | 0.656 0.006 CID_785 0.738 0.005 CID_289 | CID_289 | |
| 0.607 | 0.011 | 0.703 | Antioxidant | 0.649 0.008 CID_785 0.703 0.005 CID_289 | CID_289 | |
| 0.584 | 0.008 | 0.584 | Calcium channel L-type activator | 0.581 0.008 CID_785 0.521 0.02 CID_289 | ||
| 0.572 | 0.022 | 0.577 | Cholesterol antagonist | 0.577 0.021 CID_785 0.574 0.022 CID_289 | CID_785 | |
| 0.564 | 0.014 | 0.58 | Histamine release inhibitor | 0.562 0.014 CID_785 0.58 0.012 CID_289 | CID_289 | |
| 0.544 | 0.003 | 0.584 | GABA C receptor agonist | 0.584 0.003 CID_785 0.544 0.003 CID_289 | CID_785 | |
| 0.542 | 0.003 | 0.573 | Porphobilinogen synthase inhibitor | 0.573 0.003 CID_785 0.542 0.003 CID_289 | CID_785 | |
| 0.521 | 0.004 | 0.565 | 5 Hydroxytryptamine uptake stimulant | 0.518 0.004 CID_785 0.565 0.003 CID_289 | CID_289 | |
| 0.529 | 0.012 | 0.679 | Amyloid beta aggregation inhibitor | 0.556 0.01 CID_785 0.679 0.005 CID_289 | CID_289 | |
| 0.514 | 0.003 | 0.579 | Estrogen agonist | 0.579 0.003 CID_785 0.298 0.005 CID_289 | CID_785 | |
| 0.489 | 0.004 | 0.499 | Cystathionine beta-synthase inhibitor | 0.499 0.004 CID_785 0.493 0.004 CID_289 | CID_785 | |
| 0.504 | 0.032 | 0.504 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.501 0.033 CID_785 0.504 0.032 CID_289 | ||
| 0.467 | 0.002 | 0.473 | Creatine kinase inhibitor | 0.473 0.002 CID_785 0.466 0.002 CID_289 | CID_785 | |
| 0.528 | 0.066 | 0.615 | Apoptosis agonist | 0.553 0.06 CID_785 0.615 0.046 CID_289 | CID_289 | |
| 0.465 | 0.026 | 0.517 | Caspase 3 stimulant | 0.486 0.022 CID_785 0.517 0.018 CID_289 | CID_289 | |
| 0.45 | 0.011 | 0.45 | Anesthetic general | 0.444 0.012 CID_785 0.44 0.012 CID_289 | ||
| 0.44 | 0.003 | 0.509 | Estrogen receptor beta agonist | 0.509 0.003 CID_785 0.212 0.004 CID_289 | CID_785 | |
| 0.447 | 0.012 | 0.447 | Calcium channel activator | 0.444 0.012 CID_785 0.428 0.016 CID_289 | ||
| 0.456 | 0.039 | 0.479 | Vasodilator, peripheral | 0.459 0.038 CID_785 0.479 0.033 CID_289 | CID_289 | |
| 0.418 | 0.003 | 0.46 | Phenylalanine 4-hydroxylase inhibitor | 0.411 0.003 CID_785 0.46 0.003 CID_289 | CID_289 | |
| 0.42 | 0.009 | 0.502 | Lipid peroxidase inhibitor | 0.464 0.006 CID_785 0.502 0.005 CID_289 | CID_289 | |
| 0.407 | 0.004 | 0.465 | Succinate dehydrogenase inhibitor | 0.414 0.004 CID_785 0.465 0.003 CID_289 | CID_289 | |
| 0.454 | 0.053 | 0.487 | 15-Lipoxygenase inhibitor | 0.449 0.055 CID_785 0.487 0.043 CID_289 | CID_289 | |
| 0.404 | 0.005 | 0.416 | UDP-glucose 4-epimerase inhibitor | 0.416 0.005 CID_785 0.404 0.005 CID_289 | CID_785 | |
| 0.409 | 0.014 | 0.417 | Sodium/bile acid cotransporter inhibitor | 0.417 0.013 CID_785 0.38 0.024 CID_289 | CID_785 | |
| 0.399 | 0.004 | 0.413 | Histidine decarboxylase inhibitor | 0.413 0.004 CID_785 0.394 0.004 CID_289 | CID_785 | |
| 0.398 | 0.008 | 0.429 | NOS3 expression enhancer | 0.426 0.007 CID_785 0.429 0.007 CID_289 | CID_289 | |
| 0.399 | 0.009 | 0.403 | Amylase inhibitor | 0.403 0.009 CID_785 0.403 0.009 CID_289 | CID_289 | |
| 0.39 | 0.005 | 0.471 | M18 aspartyl aminopeptidase inhibitor | 0.404 0.005 CID_785 0.471 0.003 CID_289 | CID_289 | |
| 0.419 | 0.034 | 0.449 | 12-Lipoxygenase inhibitor | 0.412 0.036 CID_785 0.449 0.029 CID_289 | CID_289 | |
| 0.401 | 0.018 | 0.422 | RNA-directed DNA polymerase inhibitor | 0.413 0.017 CID_785 0.422 0.016 CID_289 | CID_289 | |
| 0.389 | 0.009 | 0.39 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.388 0.009 CID_785 0.39 0.009 CID_289 | CID_289 | |
| 0.434 | 0.056 | 0.446 | Transcription factor NF kappa B inhibitor | 0.437 0.056 CID_785 0.446 0.054 CID_289 | CID_289 | |
| 0.383 | 0.006 | 0.519 | Chelator | 0.44 0.005 CID_785 0.519 0.004 CID_289 | CID_289 | |
| 0.386 | 0.011 | 0.386 | Phospholipase C inhibitor | 0.384 0.012 CID_785 0.382 0.012 CID_289 | ||
| 0.414 | 0.043 | 0.417 | Streptokinase A inhibitor | 0.417 0.043 CID_785 0.401 0.047 CID_289 | CID_785 | |
| 0.371 | 0.003 | 0.435 | Estrogen receptor alpha agonist | 0.435 0.003 CID_785 0.212 0.004 CID_289 | CID_785 | |
| 0.375 | 0.007 | 0.389 | Neurotrophic factor enhancer | 0.372 0.007 CID_785 0.389 0.006 CID_289 | CID_289 | |
| 0.374 | 0.006 | 0.374 | Aldehyde dehydrogenase inhibitor | 0.372 0.006 CID_785 0.298 0.012 CID_289 | ||
| 0.387 | 0.023 | 0.401 | Pyruvate kinase inhibitor | 0.38 0.025 CID_785 0.401 0.02 CID_289 | CID_289 | |
| 0.397 | 0.039 | 0.453 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.387 0.041 CID_785 0.453 0.027 CID_289 | CID_289 | |
| 0.361 | 0.004 | 0.361 | GABA C receptor rho-2 antagonist | 0.352 0.004 CID_785 0.314 0.005 CID_289 | ||
| 0.356 | 0.005 | 0.367 | Nitric-oxide synthase stimulant | 0.367 0.004 CID_785 0.363 0.004 CID_289 | CID_785 | |
| 0.352 | 0.004 | 0.366 | Triose-phosphate isomerase inhibitor | 0.366 0.004 CID_785 0.352 0.004 CID_289 | CID_785 | |
| 0.353 | 0.006 | 0.4 | Interleukin 4 antagonist | 0.4 0.005 CID_785 0.392 0.005 CID_289 | CID_785 | |
| 0.376 | 0.032 | 0.418 | Hypoglycemic | 0.418 0.025 CID_785 0.395 0.028 CID_289 | CID_785 | |
| 0.377 | 0.034 | 0.396 | Interleukin antagonist | 0.396 0.031 CID_785 0.287 0.051 CID_289 | CID_785 | |
| 0.345 | 0.004 | 0.355 | GABA C receptor antagonist | 0.355 0.004 CID_785 0.305 0.004 CID_289 | CID_785 | |
| 0.342 | 0.005 | 0.363 | Ferrochelatase inhibitor | 0.363 0.004 CID_785 0.342 0.005 CID_289 | CID_785 | |
| 0.342 | 0.005 | 0.344 | Carbonic anhydrase III inhibitor | 0.337 0.005 CID_785 0.344 0.004 CID_289 | CID_289 | |
| 0.379 | 0.042 | 0.393 | Vasodilator, coronary | 0.381 0.042 CID_785 0.393 0.037 CID_289 | CID_289 | |
| 0.365 | 0.029 | 0.365 | Insulysin inhibitor | 0.363 0.03 CID_785 0.365 0.029 CID_289 | ||
| 0.378 | 0.045 | 0.45 | Apoptosis antagonist | 0.397 0.039 CID_785 0.45 0.028 CID_289 | CID_289 | |
| 0.371 | 0.038 | 0.384 | Hypoxia-inducible factor 1 alpha inhibitor | 0.368 0.039 CID_785 0.384 0.035 CID_289 | CID_289 | |
| 0.348 | 0.016 | 0.357 | Melanin inhibitor | 0.357 0.015 CID_785 0.347 0.016 CID_289 | CID_785 | |
| 0.356 | 0.027 | 0.382 | Interleukin agonist | 0.358 0.027 CID_785 0.382 0.022 CID_289 | CID_289 | |
| 0.356 | 0.029 | 0.356 | Sigma receptor agonist | 0.33 0.034 CID_785 0.153 0.083 CID_289 | ||
| 0.354 | 0.029 | 0.369 | DNA synthesis inhibitor | 0.369 0.026 CID_785 0.332 0.034 CID_289 | CID_785 | |
| 0.333 | 0.008 | 0.445 | 5-Lipoxygenase inhibitor | 0.356 0.007 CID_785 0.445 0.005 CID_289 | CID_289 | |
| 0.326 | 0.006 | 0.332 | Carbonic anhydrase XV inhibitor | 0.332 0.006 CID_785 0.326 0.006 CID_289 | CID_785 | |
| 0.322 | 0.006 | 0.365 | NADH dehydrogenase inhibitor | 0.365 0.005 CID_785 0.322 0.006 CID_289 | CID_785 | |
| 0.314 | 0.003 | 0.332 | Glutamate decarboxylase inhibitor | 0.332 0.003 CID_785 0.326 0.003 CID_289 | CID_785 | |
| 0.359 | 0.048 | 0.393 | Lipoxygenase inhibitor | 0.352 0.05 CID_785 0.393 0.039 CID_289 | CID_289 | |
| 0.314 | 0.005 | 0.324 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.324 0.005 CID_785 0.314 0.005 CID_289 | CID_785 | |
| 0.323 | 0.015 | 0.353 | Topoisomerase II inhibitor | 0.353 0.013 CID_785 0.308 0.017 CID_289 | CID_785 | |
| 0.428 | 0.122 | 0.558 | Antiinflammatory | 0.479 0.097 CID_785 0.558 0.065 CID_289 | CID_289 | |
| 0.351 | 0.045 | 0.368 | Interleukin 2 agonist | 0.368 0.038 CID_785 0.304 0.071 CID_289 | CID_785 | |
| 0.342 | 0.037 | 0.35 | Transcription factor STAT inhibitor | 0.343 0.037 CID_785 0.35 0.034 CID_289 | CID_289 | |
| 0.331 | 0.031 | 0.35 | Cyclic AMP phosphodiesterase inhibitor | 0.338 0.029 CID_785 0.35 0.026 CID_289 | CID_289 | |
| 0.341 | 0.05 | 0.345 | Aryl hydrocarbon receptor agonist | 0.327 0.054 CID_785 0.345 0.049 CID_289 | CID_289 | |
| 0.403 | 0.113 | 0.429 | Alpha-glucosidase inhibitor | 0.397 0.116 CID_785 0.429 0.103 CID_289 | CID_289 | |
| 0.315 | 0.026 | 0.394 | Dual specificity phosphatase inhibitor | 0.332 0.024 CID_785 0.394 0.015 CID_289 | CID_289 | |
| 0.314 | 0.026 | 0.391 | Dual specificity phosphatase 3 inhibitor | 0.329 0.024 CID_785 0.391 0.015 CID_289 | CID_289 | |
| 0.299 | 0.013 | 0.316 | NADPH oxidase inhibitor | 0.291 0.014 CID_785 0.316 0.01 CID_289 | CID_289 | |
| 0.375 | 0.089 | 0.392 | Antibacterial | 0.387 0.083 CID_785 0.392 0.08 CID_289 | CID_289 | |
| 0.29 | 0.006 | 0.331 | Mannose-6-phosphate isomerase inhibitor | 0.285 0.007 CID_785 0.331 0.004 CID_289 | CID_289 | |
| 0.301 | 0.02 | 0.309 | Interferon gamma antagonist | 0.309 0.019 CID_785 0.302 0.02 CID_289 | CID_785 | |
| 0.322 | 0.043 | 0.338 | Transcription factor STAT3 inhibitor | 0.323 0.043 CID_785 0.338 0.037 CID_289 | CID_289 | |
| 0.305 | 0.027 | 0.305 | 5 Hydroxytryptamine 1E antagonist | 0.305 0.027 CID_785 0.302 0.028 CID_289 | ||
| 0.32 | 0.044 | 0.353 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.353 0.035 CID_785 0.314 0.046 CID_289 | CID_785 | |
| 0.283 | 0.007 | 0.292 | Carbonic anhydrase VI inhibitor | 0.284 0.007 CID_785 0.292 0.006 CID_289 | CID_289 | |
| 0.277 | 0.004 | 0.278 | GABA C receptor rho-1 antagonist | 0.278 0.004 CID_785 0.245 0.004 CID_289 | CID_785 | |
| 0.281 | 0.008 | 0.295 | Adenylate kinase inhibitor | 0.295 0.007 CID_785 0.281 0.008 CID_289 | CID_785 | |
| 0.274 | 0.003 | 0.287 | DOPA decarboxylase inhibitor | 0.287 0.003 CID_785 0.279 0.003 CID_289 | CID_785 | |
| 0.289 | 0.019 | 0.294 | Monophenol monooxygenase inhibitor | 0.294 0.018 CID_785 0.289 0.019 CID_289 | CID_785 | |
| 0.308 | 0.039 | 0.369 | Nitric oxide antagonist | 0.343 0.033 CID_785 0.369 0.029 CID_289 | CID_289 | |
| 0.313 | 0.044 | 0.335 | Angiogenesis stimulant | 0.335 0.037 CID_785 0.331 0.038 CID_289 | CID_785 | |
| 0.273 | 0.005 | 0.277 | CF transmembrane conductance regulator agonist | 0.277 0.005 CID_785 0.242 0.008 CID_289 | CID_785 | |
| 0.272 | 0.004 | 0.275 | Keratolytic | 0.275 0.004 CID_785 0.269 0.005 CID_289 | CID_785 | |
| 0.269 | 0.003 | 0.289 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.289 0.003 CID_785 0.185 0.004 CID_289 | CID_785 | |
| 0.274 | 0.009 | 0.291 | Topoisomerase II alpha inhibitor | 0.291 0.008 CID_785 0.236 0.011 CID_289 | CID_785 | |
| 0.291 | 0.028 | 0.308 | Peptidyltransferase inhibitor | 0.304 0.023 CID_785 0.308 0.022 CID_289 | CID_289 | |
| 0.322 | 0.062 | 0.338 | Spasmolytic | 0.314 0.065 CID_785 0.338 0.056 CID_289 | CID_289 | |
| 0.27 | 0.009 | 0.27 | 5 Hydroxytryptamine 3E antagonist | 0.267 0.01 CID_785 0.27 0.009 CID_289 | ||
| 0.264 | 0.005 | 0.264 | Macrophage migration inhibitory factor inhibitor | 0.262 0.005 CID_785 0.256 0.005 CID_289 | ||
| 0.262 | 0.004 | 0.262 | Prolactin inhibitor | 0.259 0.004 CID_785 0.255 0.004 CID_289 | ||
| 0.294 | 0.037 | 0.294 | Gastrin inhibitor | 0.292 0.039 CID_785 0.288 0.042 CID_289 | ||
| 0.286 | 0.031 | 0.301 | DNA methyltransferase I inhibitor | 0.289 0.03 CID_785 0.301 0.026 CID_289 | CID_289 | |
| 0.326 | 0.074 | 0.338 | Antithrombotic | 0.333 0.071 CID_785 0.338 0.069 CID_289 | CID_289 | |
| 0.307 | 0.054 | 0.325 | DNA damaging | 0.308 0.054 CID_785 0.325 0.048 CID_289 | CID_289 | |
| 0.267 | 0.014 | 0.267 | Hexokinase inhibitor | 0.263 0.015 CID_785 0.242 0.019 CID_289 | ||
| 0.259 | 0.007 | 0.271 | Alcohol dehydrogenase inhibitor | 0.271 0.006 CID_785 0.229 0.009 CID_289 | CID_785 | |
| 0.271 | 0.022 | 0.279 | Protein kinase stimulant | 0.279 0.02 CID_785 0.272 0.021 CID_289 | CID_785 | |
| 0.259 | 0.01 | 0.277 | Farnesoid X receptor antagonist | 0.277 0.008 CID_785 0.223 0.016 CID_289 | CID_785 | |
| 0.292 | 0.045 | 0.292 | Psychostimulant | 0.286 0.046 CID_785 0.285 0.047 CID_289 | ||
| 0.252 | 0.005 | 0.252 | 5 Hydroxytryptamine 3A agonist | 0.251 0.005 CID_785 0.224 0.009 CID_289 | ||
| 0.252 | 0.005 | 0.288 | HIV-1 integrase (Overall Integration) inhibitor | 0.247 0.005 CID_785 0.288 0.004 CID_289 | CID_289 | |
| 0.245 | 0.004 | 0.258 | Adenylate cyclase stimulant | 0.251 0.004 CID_785 0.258 0.004 CID_289 | CID_289 | |
| 0.246 | 0.007 | 0.466 | HIV-1 integrase (3'-Processing) inhibitor | 0.282 0.005 CID_785 0.466 0.004 CID_289 | CID_289 | |
| 0.294 | 0.055 | 0.323 | Dyrk kinase inhibitor | 0.323 0.045 CID_785 0.284 0.058 CID_289 | CID_785 | |
| 0.261 | 0.023 | 0.262 | Heat shock protein 90 alpha antagonist | 0.262 0.023 CID_785 0.253 0.025 CID_289 | CID_785 | |
| 0.251 | 0.013 | 0.258 | ATPase inhibitor | 0.25 0.014 CID_785 0.258 0.012 CID_289 | CID_289 | |
| 0.274 | 0.037 | 0.293 | DNA methylase inhibitor | 0.277 0.035 CID_785 0.293 0.03 CID_289 | CID_289 | |
| 0.247 | 0.01 | 0.254 | Toll-Like receptor 2 antagonist | 0.248 0.009 CID_785 0.254 0.009 CID_289 | CID_289 | |
| 0.259 | 0.024 | 0.259 | 3C-like protease (Human coronavirus) inhibitor | 0.256 0.025 CID_785 0.242 0.031 CID_289 | ||
| 0.33 | 0.096 | 0.33 | Calpain 2 inhibitor | 0.323 0.101 CID_785 0.283 0.125 CID_289 | ||
| 0.253 | 0.02 | 0.255 | Neurotensin receptor agonist | 0.255 0.02 CID_785 0.222 0.027 CID_289 | CID_785 | |
| 0.24 | 0.008 | 0.261 | Phosphofructokinase-1 inhibitor | 0.261 0.007 CID_785 0.24 0.008 CID_289 | CID_785 | |
| 0.249 | 0.017 | 0.272 | Topoisomerase I inhibitor | 0.272 0.014 CID_785 0.24 0.018 CID_289 | CID_785 | |
| 0.24 | 0.008 | 0.246 | Arachidonic acid antagonist | 0.243 0.007 CID_785 0.246 0.006 CID_289 | CID_289 | |
| 0.26 | 0.028 | 0.301 | Protein-tyrosine phosphatase inhibitor | 0.274 0.025 CID_785 0.301 0.019 CID_289 | CID_289 | |
| 0.243 | 0.013 | 0.252 | Catenin beta inhibitor | 0.252 0.01 CID_785 0.178 0.055 CID_289 | CID_785 | |
| 0.249 | 0.021 | 0.253 | Heat shock protein 90 antagonist | 0.253 0.02 CID_785 0.24 0.024 CID_289 | CID_785 | |
| 0.268 | 0.04 | 0.268 | Neuropeptide Y2 antagonist | 0.265 0.043 CID_785 0.243 0.064 CID_289 | ||
| 0.244 | 0.019 | 0.252 | Cholesterol synthesis inhibitor | 0.251 0.018 CID_785 0.252 0.017 CID_289 | CID_289 | |
| 0.259 | 0.033 | 0.401 | Mcl-1 antagonist | 0.272 0.029 CID_785 0.401 0.01 CID_289 | CID_289 | |
| 0.229 | 0.008 | 0.249 | Opioid kappa receptor antagonist | 0.249 0.007 CID_785 0.105 0.031 CID_289 | CID_785 | |
| 0.229 | 0.01 | 0.25 | Opioid antagonist | 0.25 0.008 CID_785 0.11 0.041 CID_289 | CID_785 | |
| 0.26 | 0.041 | 0.264 | Growth hormone agonist | 0.264 0.04 CID_785 0.185 0.065 CID_289 | CID_785 | |
| 0.296 | 0.079 | 0.306 | Immunostimulant | 0.306 0.077 CID_785 0.286 0.083 CID_289 | CID_785 | |
| 0.249 | 0.033 | 0.272 | Amyloid beta precursor protein antagonist | 0.262 0.028 CID_785 0.272 0.025 CID_289 | CID_289 | |
| 0.226 | 0.011 | 0.234 | Carbonic anhydrase XIII inhibitor | 0.234 0.01 CID_785 0.232 0.01 CID_289 | CID_785 | |
| 0.275 | 0.06 | 0.307 | Antiamyloidogenic | 0.282 0.058 CID_785 0.307 0.049 CID_289 | CID_289 | |
| 0.215 | 0.002 | 0.224 | Dopamine D5 agonist | 0.213 0.002 CID_785 0.224 0.002 CID_289 | CID_289 | |
| 0.262 | 0.049 | 0.267 | MAP kinase kinase 2 inhibitor | 0.267 0.047 CID_785 0.251 0.053 CID_289 | CID_785 | |
| 0.22 | 0.008 | 0.381 | HIV-1 integrase (Strand Transfer) inhibitor | 0.252 0.006 CID_785 0.381 0.004 CID_289 | CID_289 | |
| 0.22 | 0.008 | 0.22 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.213 0.008 CID_785 0.207 0.009 CID_289 | ||
| 0.247 | 0.036 | 0.254 | Insulin sensitizer | 0.247 0.036 CID_785 0.254 0.032 CID_289 | CID_289 | |
| 0.221 | 0.011 | 0.222 | Potassium channel (Ca-activated) activator | 0.222 0.011 CID_785 0.211 0.012 CID_289 | CID_785 | |
| 0.219 | 0.009 | 0.221 | Photosensitizer | 0.221 0.009 CID_785 0.196 0.014 CID_289 | CID_785 | |
| 0.213 | 0.004 | 0.215 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.215 0.004 CID_785 0.166 0.004 CID_289 | CID_785 | |
| 0.222 | 0.013 | 0.222 | Cyclooxygenase 3 inhibitor | 0.22 0.013 CID_785 0.221 0.013 CID_289 | ||
| 0.268 | 0.06 | 0.344 | Vasodilator | 0.289 0.052 CID_785 0.344 0.035 CID_289 | CID_289 | |
| 0.228 | 0.021 | 0.238 | Cell wall synthesis inhibitor | 0.238 0.018 CID_785 0.231 0.02 CID_289 | CID_785 | |
| 0.235 | 0.028 | 0.261 | Bone formation stimulant | 0.261 0.023 CID_785 0.168 0.047 CID_289 | CID_785 | |
| 0.215 | 0.009 | 0.233 | Opioid delta receptor antagonist | 0.233 0.007 CID_785 0.099 0.03 CID_289 | CID_785 | |
| 0.214 | 0.008 | 0.214 | TRPA1 agonist | 0.21 0.009 CID_785 0.196 0.011 CID_289 | ||
| 0.214 | 0.009 | 0.231 | Glutamate dehydrogenase inhibitor | 0.231 0.008 CID_785 0.214 0.009 CID_289 | CID_785 | |
| 0.215 | 0.01 | 0.231 | Mucolytic | 0.219 0.01 CID_785 0.231 0.008 CID_289 | CID_289 | |
| 0.248 | 0.044 | 0.261 | Non-steroidal antiinflammatory agent | 0.248 0.044 CID_785 0.261 0.039 CID_289 | CID_289 | |
| 0.228 | 0.026 | 0.246 | Cyclooxygenase 1 inhibitor | 0.246 0.022 CID_785 0.241 0.023 CID_289 | CID_785 | |
| 0.207 | 0.005 | 0.213 | Heat shock protein 70 antagonist | 0.207 0.005 CID_785 0.213 0.005 CID_289 | CID_289 | |
| 0.246 | 0.044 | 0.296 | Hepatoprotectant | 0.278 0.036 CID_785 0.296 0.031 CID_289 | CID_289 | |
| 0.218 | 0.017 | 0.242 | Expectorant | 0.222 0.016 CID_785 0.242 0.014 CID_289 | CID_289 | |
| 0.211 | 0.01 | 0.221 | MAP kinase kinase 4 inhibitor | 0.221 0.008 CID_785 0.159 0.046 CID_289 | CID_785 | |
| 0.208 | 0.009 | 0.213 | Papain-like protease (SARS coronavirus) inhibitor | 0.213 0.008 CID_785 0.196 0.011 CID_289 | CID_785 | |
| 0.216 | 0.017 | 0.223 | Xanthine oxidase inhibitor | 0.223 0.015 CID_785 0.222 0.016 CID_289 | CID_785 | |
| 0.201 | 0.003 | 0.204 | Ca2+-transporting ATPase inhibitor | 0.204 0.003 CID_785 0.201 0.003 CID_289 | CID_785 | |
| 0.202 | 0.004 | 0.202 | GABA aminotransferase inhibitor | 0.2 0.004 CID_785 0.187 0.005 CID_289 | ||
| 0.232 | 0.035 | 0.249 | Histone acetyltransferase inhibitor | 0.23 0.036 CID_785 0.249 0.026 CID_289 | CID_289 | |
| 0.249 | 0.052 | 0.249 | ErbB-1 antagonist | 0.245 0.054 CID_785 0.183 0.111 CID_289 | ||
| 0.208 | 0.012 | 0.211 | Beta glucuronidase inhibitor | 0.203 0.012 CID_785 0.211 0.012 CID_289 | CID_289 | |
| 0.214 | 0.018 | 0.216 | Aminopeptidase B inhibitor | 0.216 0.018 CID_785 0.202 0.021 CID_289 | CID_785 | |
| 0.198 | 0.003 | 0.204 | D-Ala-D-Ala ligase inhibitor | 0.194 0.004 CID_785 0.204 0.003 CID_289 | CID_289 | |
| 0.202 | 0.009 | 0.224 | Opioid mu receptor antagonist | 0.224 0.007 CID_785 0.092 0.035 CID_289 | CID_785 | |
| 0.215 | 0.023 | 0.252 | Adenylate cyclase inhibitor | 0.217 0.023 CID_785 0.252 0.019 CID_289 | CID_289 | |
| 0.197 | 0.007 | 0.218 | Potassium channel large-conductance Ca-activated activator | 0.218 0.005 CID_785 0.145 0.012 CID_289 | CID_785 | |
| 0.192 | 0.003 | 0.192 | Estrogen-related receptor beta agonist | 0.19 0.003 CID_785 0.167 0.003 CID_289 | ||
| 0.294 | 0.105 | 0.333 | Prostaglandin dehydrogenase inhibitor | 0.288 0.107 CID_785 0.333 0.089 CID_289 | CID_289 | |
| 0.203 | 0.015 | 0.208 | Catalase inhibitor | 0.208 0.014 CID_785 0.188 0.018 CID_289 | CID_785 | |
| 0.2 | 0.013 | 0.238 | Uric acid excretion stimulant | 0.222 0.01 CID_785 0.238 0.008 CID_289 | CID_289 | |
| 0.193 | 0.008 | 0.215 | Carbamoyl phosphate synthetase inhibitor | 0.215 0.007 CID_785 0.193 0.008 CID_289 | CID_785 | |
| 0.214 | 0.028 | 0.239 | Alkaline phosphatase inhibitor | 0.216 0.028 CID_785 0.239 0.022 CID_289 | CID_289 | |
| 0.197 | 0.013 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | 0.199 0.012 CID_785 0.205 0.009 CID_289 | CID_289 | |
| 0.193 | 0.009 | 0.197 | Electrolyte absorption antagonist | 0.197 0.008 CID_785 0.193 0.009 CID_289 | CID_785 | |
| 0.21 | 0.028 | 0.258 | Death-associated protein kinase 2 inhibitor | 0.212 0.027 CID_785 0.258 0.012 CID_289 | CID_289 | |
| 0.188 | 0.006 | 0.212 | Biliverdin reductase inhibitor | 0.212 0.005 CID_785 0.188 0.006 CID_289 | CID_785 | |
| 0.188 | 0.006 | 0.202 | NMDA 2B receptor antagonist | 0.202 0.005 CID_785 0.083 0.02 CID_289 | CID_785 | |
| 0.204 | 0.027 | 0.278 | DNA polymerase I inhibitor | 0.228 0.021 CID_785 0.278 0.013 CID_289 | CID_289 | |
| 0.181 | 0.005 | 0.188 | Glutamate release inhibitor | 0.188 0.005 CID_785 0.173 0.006 CID_289 | CID_785 | |
| 0.204 | 0.028 | 0.231 | Protein-tyrosine phosphatase 1B inhibitor | 0.218 0.024 CID_785 0.231 0.021 CID_289 | CID_289 | |
| 0.245 | 0.07 | 0.245 | Calpain inhibitor | 0.242 0.073 CID_785 0.243 0.071 CID_289 | ||
| 0.19 | 0.015 | 0.194 | Interleukin 8 antagonist | 0.187 0.017 CID_785 0.194 0.014 CID_289 | CID_289 | |
| 0.225 | 0.052 | 0.234 | I kappa B kinase epsilon inhibitor | 0.234 0.046 CID_785 0.231 0.048 CID_289 | CID_785 | |
| 0.18 | 0.007 | 0.286 | Alpha tubulin antagonist | 0.211 0.005 CID_785 0.286 0.004 CID_289 | CID_289 | |
| 0.179 | 0.007 | 0.185 | Interleukin 12 antagonist | 0.185 0.007 CID_785 0.129 0.022 CID_289 | CID_785 | |
| 0.187 | 0.016 | 0.202 | Vanilloid 1 agonist | 0.188 0.015 CID_785 0.202 0.011 CID_289 | CID_289 | |
| 0.174 | 0.004 | 0.181 | GABA B receptor agonist | 0.177 0.004 CID_785 0.181 0.004 CID_289 | CID_289 | |
| 0.184 | 0.013 | 0.192 | Sphingosine 1-phosphate receptor 2 antagonist | 0.187 0.011 CID_785 0.192 0.01 CID_289 | CID_289 | |
| 0.174 | 0.004 | 0.198 | Granulocyte macrophage colony stimulating factor agonist | 0.172 0.004 CID_785 0.198 0.003 CID_289 | CID_289 | |
| 0.205 | 0.035 | 0.364 | Tubulin antagonist | 0.222 0.031 CID_785 0.364 0.014 CID_289 | CID_289 | |
| 0.176 | 0.006 | 0.18 | Carbonic anhydrase VB inhibitor | 0.177 0.006 CID_785 0.18 0.006 CID_289 | CID_289 | |
| 0.173 | 0.005 | 0.174 | Purinergic P2X1 antagonist | 0.174 0.005 CID_785 0.173 0.005 CID_289 | CID_785 | |
| 0.177 | 0.009 | 0.187 | Argininosuccinate synthase inhibitor | 0.187 0.008 CID_785 0.177 0.009 CID_289 | CID_785 | |
| 0.289 | 0.122 | 0.311 | Immunosuppressant | 0.311 0.108 CID_785 0.307 0.11 CID_289 | CID_785 | |
| 0.177 | 0.011 | 0.177 | Transcription factor STAT6 inhibitor | 0.175 0.011 CID_785 0.169 0.013 CID_289 | ||
| 0.17 | 0.005 | 0.174 | Glycine receptor agonist | 0.174 0.005 CID_785 0.17 0.005 CID_289 | CID_785 | |
| 0.168 | 0.004 | 0.171 | Aconitate hydratase inhibitor | 0.171 0.004 CID_785 0.168 0.004 CID_289 | CID_785 | |
| 0.189 | 0.026 | 0.189 | Cathepsin H inhibitor | 0.186 0.027 CID_785 0.177 0.03 CID_289 | ||
| 0.175 | 0.011 | 0.19 | Analgesic, opioid | 0.19 0.01 CID_785 0.08 0.048 CID_289 | CID_785 | |
| 0.222 | 0.06 | 0.294 | Platelet adhesion inhibitor | 0.234 0.055 CID_785 0.294 0.036 CID_289 | CID_289 | |
| 0.207 | 0.044 | 0.221 | Cytidine deaminase inhibitor | 0.205 0.046 CID_785 0.221 0.038 CID_289 | CID_289 | |
| 0.172 | 0.01 | 0.177 | Estrogen receptor alpha antagonist | 0.177 0.009 CID_785 0.147 0.012 CID_289 | CID_785 | |
| 0.171 | 0.009 | 0.175 | Anabolic | 0.175 0.008 CID_785 0.165 0.011 CID_289 | CID_785 | |
| 0.18 | 0.019 | 0.18 | Protein kinase C gamma inhibitor | 0.175 0.02 CID_785 0.174 0.021 CID_289 | ||
| 0.167 | 0.006 | 0.25 | HIV-1 integrase inhibitor | 0.186 0.005 CID_785 0.25 0.004 CID_289 | CID_289 | |
| 0.201 | 0.04 | 0.201 | MAO inhibitor | 0.193 0.043 CID_785 0.193 0.043 CID_289 | ||
| 0.17 | 0.01 | 0.173 | Carbonic anhydrase V inhibitor | 0.171 0.01 CID_785 0.173 0.01 CID_289 | CID_289 | |
| 0.183 | 0.023 | 0.191 | Falcipain 3 inhibitor | 0.182 0.024 CID_785 0.191 0.02 CID_289 | CID_289 | |
| 0.208 | 0.049 | 0.213 | Tumour necrosis factor antagonist | 0.213 0.046 CID_785 0.212 0.047 CID_289 | CID_785 | |
| 0.167 | 0.008 | 0.177 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.177 0.007 CID_785 0.167 0.008 CID_289 | CID_785 | |
| 0.189 | 0.031 | 0.189 | MAO A inhibitor | 0.18 0.033 CID_785 0.182 0.033 CID_289 | ||
| 0.165 | 0.008 | 0.183 | Acyl-CoA dehydrogenase inhibitor | 0.183 0.006 CID_785 0.165 0.008 CID_289 | CID_785 | |
| 0.182 | 0.025 | 0.195 | Microtubule formation inhibitor | 0.185 0.024 CID_785 0.195 0.021 CID_289 | CID_289 | |
| 0.165 | 0.008 | 0.166 | Lanosterol 14 alpha demethylase inhibitor | 0.166 0.007 CID_785 0.15 0.011 CID_289 | CID_785 | |
| 0.198 | 0.043 | 0.198 | Phospholipase A2 inhibitor | 0.196 0.044 CID_785 0.196 0.045 CID_289 | ||
| 0.176 | 0.021 | 0.176 | Pregnane X receptor agonist | 0.175 0.022 CID_785 0.176 0.021 CID_289 | ||
| 0.172 | 0.019 | 0.172 | NMDA receptor antagonist | 0.168 0.02 CID_785 0.132 0.03 CID_289 | ||
| 0.181 | 0.028 | 0.181 | Nav1.6 sodium channel blocker | 0.18 0.028 CID_785 0.166 0.038 CID_289 | ||
| 0.162 | 0.009 | 0.168 | Myeloperoxidase inhibitor | 0.159 0.009 CID_785 0.168 0.008 CID_289 | CID_289 | |
| 0.163 | 0.011 | 0.274 | Beta tubulin antagonist | 0.181 0.009 CID_785 0.274 0.005 CID_289 | CID_289 | |
| 0.174 | 0.021 | 0.188 | Antineoplastic alkaloid | 0.188 0.017 CID_785 0.187 0.017 CID_289 | CID_785 | |
| 0.163 | 0.01 | 0.163 | Histamine N-methyltransferase inhibitor | 0.161 0.011 CID_785 0.146 0.015 CID_289 | ||
| 0.171 | 0.019 | 0.171 | Sphingosine 1-phosphate receptor 4 antagonist | 0.17 0.019 CID_785 0.16 0.025 CID_289 | ||
| 0.165 | 0.014 | 0.171 | Toll-Like receptor 4 antagonist | 0.171 0.012 CID_785 0.156 0.018 CID_289 | CID_785 | |
| 0.166 | 0.017 | 0.166 | Protein kinase C zeta inhibitor | 0.162 0.017 CID_785 0.161 0.018 CID_289 | ||
| 0.16 | 0.011 | 0.162 | Aminopeptidase I inhibitor | 0.162 0.011 CID_785 0.147 0.013 CID_289 | CID_785 | |
| 0.181 | 0.032 | 0.188 | Alkylator | 0.188 0.03 CID_785 0.175 0.035 CID_289 | CID_785 | |
| 0.193 | 0.045 | 0.225 | Interleukin 6 antagonist | 0.202 0.039 CID_785 0.225 0.029 CID_289 | CID_289 | |
| 0.163 | 0.014 | 0.163 | NMDA 2 receptor antagonist | 0.158 0.015 CID_785 0.122 0.023 CID_289 | ||
| 0.16 | 0.012 | 0.16 | Adrenaline agonist | 0.159 0.013 CID_785 0.158 0.013 CID_289 | ||
| 0.305 | 0.158 | 0.374 | Cyclophilin D inhibitor | 0.345 0.126 CID_785 0.374 0.106 CID_289 | CID_289 | |
| 0.151 | 0.006 | 0.151 | NMDA receptor subunit 3B antagonist | 0.149 0.006 CID_785 0.104 0.01 CID_289 | ||
| 0.163 | 0.018 | 0.166 | Urease inhibitor | 0.162 0.018 CID_785 0.166 0.016 CID_289 | CID_289 | |
| 0.164 | 0.019 | 0.164 | Sphingomyelinase inhibitor | 0.162 0.02 CID_785 0.164 0.019 CID_289 | ||
| 0.153 | 0.01 | 0.172 | Aldose reductase inhibitor | 0.171 0.009 CID_785 0.172 0.009 CID_289 | CID_289 | |
| 0.152 | 0.01 | 0.153 | Carbonic anhydrase VA inhibitor | 0.153 0.01 CID_785 0.153 0.01 CID_289 | CID_289 | |
| 0.156 | 0.015 | 0.156 | Thioredoxin inhibitor | 0.156 0.015 CID_785 0.144 0.019 CID_289 | ||
| 0.147 | 0.006 | 0.147 | Estradiol 17 beta-dehydrogenase inhibitor | 0.143 0.006 CID_785 0.134 0.007 CID_289 | ||
| 0.148 | 0.007 | 0.149 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.146 0.008 CID_785 0.149 0.007 CID_289 | CID_289 | |
| 0.162 | 0.021 | 0.166 | AMP-activated protein kinase stimulant | 0.166 0.019 CID_785 0.165 0.02 CID_289 | CID_785 | |
| 0.162 | 0.022 | 0.164 | DNA repair enzyme inhibitor | 0.162 0.022 CID_785 0.164 0.021 CID_289 | CID_289 | |
| 0.143 | 0.004 | 0.143 | CC chemokine 5 receptor agonist | 0.141 0.004 CID_785 0.126 0.007 CID_289 | ||
| 0.151 | 0.016 | 0.151 | Acetylcholine release stimulant | 0.149 0.017 CID_785 0.146 0.019 CID_289 | ||
| 0.171 | 0.038 | 0.171 | Neuropeptide Y1 antagonist | 0.17 0.039 CID_785 0.152 0.062 CID_289 | ||
| 0.183 | 0.05 | 0.183 | Acetylcholine M1 receptor antagonist | 0.182 0.051 CID_785 0.182 0.051 CID_289 | ||
| 0.154 | 0.021 | 0.16 | Androgen antagonist | 0.16 0.02 CID_785 0.145 0.024 CID_289 | CID_785 | |
| 0.149 | 0.017 | 0.149 | CYP2A6 inhibitor | 0.149 0.016 CID_785 0.131 0.022 CID_289 | ||
| 0.16 | 0.028 | 0.173 | Bronchodilator | 0.173 0.024 CID_785 0.158 0.029 CID_289 | CID_785 | |
| 0.14 | 0.008 | 0.158 | Opioid mu receptor agonist | 0.158 0.006 CID_785 0.046 0.032 CID_289 | CID_785 | |
| 0.135 | 0.004 | 0.135 | Glutamate (mGluR7) antagonist | 0.132 0.004 CID_785 0.127 0.004 CID_289 | ||
| 0.136 | 0.005 | 0.145 | Topoisomerase II beta inhibitor | 0.137 0.005 CID_785 0.145 0.005 CID_289 | CID_289 | |
| 0.133 | 0.003 | 0.136 | MAP kinase kinase 7 inhibitor | 0.136 0.003 CID_785 0.121 0.004 CID_289 | CID_785 | |
| 0.131 | 0.002 | 0.146 | Estrogen-related receptor beta antagonist | 0.146 0.002 CID_785 0.072 0.004 CID_289 | CID_785 | |
| 0.177 | 0.049 | 0.2 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.2 0.042 CID_785 0.177 0.049 CID_289 | CID_785 | |
| 0.163 | 0.037 | 0.172 | Antibacterial (Helicobacter pylori) | 0.164 0.036 CID_785 0.172 0.032 CID_289 | CID_289 | |
| 0.137 | 0.011 | 0.137 | Glycine receptor antagonist | 0.137 0.011 CID_785 0.137 0.011 CID_289 | ||
| 0.167 | 0.042 | 0.181 | Anesthetic local | 0.16 0.044 CID_785 0.181 0.037 CID_289 | CID_289 | |
| 0.13 | 0.005 | 0.136 | Heat shock protein 90 beta antagonist | 0.136 0.005 CID_785 0.135 0.005 CID_289 | CID_785 | |
| 0.128 | 0.004 | 0.216 | Catechol O-methyltransferase inhibitor | 0.145 0.004 CID_785 0.216 0.002 CID_289 | CID_289 | |
| 0.135 | 0.012 | 0.135 | Sphingosine 1-phosphate receptor 4 agonist | 0.135 0.012 CID_785 0.12 0.017 CID_289 | ||
| 0.147 | 0.025 | 0.15 | Breast cancer-resistant protein inhibitor | 0.15 0.024 CID_785 0.137 0.029 CID_289 | CID_785 | |
| 0.135 | 0.015 | 0.141 | Phosphodiesterase 6D inhibitor | 0.134 0.015 CID_785 0.141 0.012 CID_289 | CID_289 | |
| 0.155 | 0.036 | 0.155 | MAO B inhibitor | 0.149 0.038 CID_785 0.145 0.039 CID_289 | ||
| 0.131 | 0.013 | 0.132 | Bile acid receptor antagonist | 0.132 0.012 CID_785 0.129 0.013 CID_289 | CID_785 | |
| 0.163 | 0.044 | 0.17 | MAP kinase kinase inhibitor | 0.17 0.041 CID_785 0.139 0.058 CID_289 | CID_785 | |
| 0.148 | 0.029 | 0.149 | Caspase 3 inhibitor | 0.147 0.03 CID_785 0.149 0.029 CID_289 | CID_289 | |
| 0.148 | 0.03 | 0.148 | Mediator release inhibitor | 0.146 0.03 CID_785 0.147 0.03 CID_289 | ||
| 0.168 | 0.05 | 0.179 | Hemostatic | 0.173 0.047 CID_785 0.179 0.043 CID_289 | CID_289 | |
| 0.139 | 0.021 | 0.143 | MAP kinase kinase 1 inhibitor | 0.143 0.019 CID_785 0.14 0.021 CID_289 | CID_785 | |
| 0.139 | 0.022 | 0.139 | Interleukin 1 beta converting enzyme inhibitor | 0.138 0.023 CID_785 0.133 0.026 CID_289 | ||
| 0.131 | 0.014 | 0.27 | Vanilloid agonist | 0.142 0.012 CID_785 0.27 0.005 CID_289 | CID_289 | |
| 0.145 | 0.029 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.024 CID_785 0.145 0.029 CID_289 | CID_785 | |
| 0.125 | 0.009 | 0.14 | Maillard reaction inhibitor | 0.131 0.008 CID_785 0.14 0.007 CID_289 | CID_289 | |
| 0.133 | 0.018 | 0.138 | Ornithine decarboxylase inhibitor | 0.137 0.016 CID_785 0.138 0.015 CID_289 | CID_289 | |
| 0.132 | 0.017 | 0.148 | Glutathione S-transferase inhibitor | 0.134 0.017 CID_785 0.148 0.012 CID_289 | CID_289 | |
| 0.124 | 0.009 | 0.125 | Beta 3 adrenoreceptor antagonist | 0.123 0.009 CID_785 0.125 0.009 CID_289 | CID_289 | |
| 0.118 | 0.004 | 0.126 | Glucose-6-phosphate isomerase inhibitor | 0.126 0.003 CID_785 0.118 0.004 CID_289 | CID_785 | |
| 0.119 | 0.007 | 0.119 | NMDA receptor subunit 3A antagonist | 0.116 0.007 CID_785 0.081 0.011 CID_289 | ||
| 0.122 | 0.01 | 0.122 | NMDA 2C receptor antagonist | 0.12 0.01 CID_785 0.094 0.018 CID_289 | ||
| 0.146 | 0.034 | 0.146 | Nav1.1 sodium channel blocker | 0.135 0.039 CID_785 | ||
| 0.178 | 0.066 | 0.183 | Antipruritic | 0.183 0.061 CID_785 0.164 0.08 CID_289 | CID_785 | |
| 0.122 | 0.011 | 0.129 | Xanthine dehydrogenase inhibitor | 0.126 0.01 CID_785 0.129 0.009 CID_289 | CID_289 | |
| 0.117 | 0.006 | 0.119 | Glutamate (mGluR6) antagonist | 0.119 0.006 CID_785 0.117 0.006 CID_289 | CID_785 | |
| 0.126 | 0.015 | 0.131 | Histone deacetylase SIRT1 stimulant | 0.131 0.014 CID_785 0.106 0.024 CID_289 | CID_785 | |
| 0.126 | 0.015 | 0.131 | Histone deacetylase stimulant | 0.131 0.014 CID_785 0.106 0.024 CID_289 | CID_785 | |
| 0.168 | 0.058 | 0.182 | Cyclooxygenase inhibitor | 0.177 0.052 CID_785 0.182 0.049 CID_289 | CID_289 | |
| 0.17 | 0.06 | 0.176 | Cyclin-dependent kinase 3 inhibitor | 0.176 0.053 CID_785 | CID_785 | |
| 0.113 | 0.004 | 0.117 | Dopamine beta hydroxylase inhibitor | 0.117 0.003 CID_785 0.115 0.003 CID_289 | CID_785 | |
| 0.15 | 0.041 | 0.159 | Beta amyloid protein antagonist | 0.159 0.034 CID_785 0.157 0.036 CID_289 | CID_785 | |
| 0.169 | 0.061 | 0.175 | Diuretic | 0.171 0.06 CID_785 0.175 0.057 CID_289 | CID_289 | |
| 0.167 | 0.059 | 0.19 | Insulin secretagoues | 0.172 0.054 CID_785 0.19 0.041 CID_289 | CID_289 | |
| 0.125 | 0.018 | 0.212 | CDC25A inhibitor | 0.131 0.016 CID_785 0.212 0.005 CID_289 | CID_289 | |
| 0.123 | 0.016 | 0.127 | mTOR complex 2 inhibitor | 0.126 0.015 CID_785 0.127 0.014 CID_289 | CID_289 | |
| 0.125 | 0.019 | 0.277 | Dopamine agonist | 0.132 0.018 CID_785 0.277 0.005 CID_289 | CID_289 | |
| 0.116 | 0.011 | 0.128 | Opioid agonist | 0.128 0.009 CID_785 | CID_785 | |
| 0.142 | 0.037 | 0.147 | Nav1.4 sodium channel blocker | 0.147 0.035 CID_785 0.095 0.084 CID_289 | CID_785 | |
| 0.11 | 0.005 | 0.117 | Sphingosine kinase 2 inhibitor | 0.112 0.005 CID_785 0.117 0.005 CID_289 | CID_289 | |
| 0.125 | 0.021 | 0.127 | Interleukin 5 antagonist | 0.127 0.019 CID_785 0.084 0.065 CID_289 | CID_785 | |
| 0.112 | 0.009 | 0.112 | Phospholipase D inhibitor | 0.111 0.009 CID_785 0.107 0.011 CID_289 | ||
| 0.127 | 0.024 | 0.127 | Glutamate (mGluR7) agonist | 0.125 0.026 CID_785 0.127 0.024 CID_289 | ||
| 0.107 | 0.004 | 0.115 | Dihydroorotate oxidase inhibitor | 0.112 0.004 CID_785 0.115 0.004 CID_289 | CID_289 | |
| 0.119 | 0.017 | 0.126 | Leukotriene synthesis inhibitor | 0.126 0.015 CID_785 0.124 0.015 CID_289 | CID_785 | |
| 0.114 | 0.012 | 0.156 | CDC25B inhibitor | 0.118 0.011 CID_785 0.156 0.006 CID_289 | CID_289 | |
| 0.106 | 0.004 | 0.11 | Ryanodine receptor antagonist | 0.11 0.004 CID_785 0.106 0.004 CID_289 | CID_785 | |
| 0.116 | 0.014 | 0.117 | NMDA receptor agonist | 0.117 0.014 CID_785 0.109 0.016 CID_289 | CID_785 | |
| 0.104 | 0.004 | 0.106 | Adenylate cyclase 1 inhibitor | 0.106 0.004 CID_785 0.1 0.004 CID_289 | CID_785 | |
| 0.122 | 0.022 | 0.126 | Somatostatin 1 agonist | 0.126 0.021 CID_785 0.079 0.053 CID_289 | CID_785 | |
| 0.108 | 0.008 | 0.116 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.105 0.009 CID_785 0.116 0.007 CID_289 | CID_289 | |
| 0.111 | 0.011 | 0.118 | Androgen agonist | 0.118 0.01 CID_785 0.1 0.014 CID_289 | CID_785 | |
| 0.102 | 0.003 | 0.112 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.112 0.002 CID_785 0.102 0.003 CID_289 | CID_785 | |
| 0.124 | 0.026 | 0.124 | Cathepsin G inhibitor | 0.119 0.027 CID_785 0.116 0.028 CID_289 | ||
| 0.101 | 0.004 | 0.106 | Alpha 1d adrenoreceptor agonist | 0.099 0.004 CID_785 0.106 0.004 CID_289 | CID_289 | |
| 0.107 | 0.01 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.106 0.01 CID_785 0.107 0.01 CID_289 | ||
| 0.109 | 0.011 | 0.109 | NMDA 2A receptor antagonist | 0.105 0.012 CID_785 0.083 0.019 CID_289 | ||
| 0.102 | 0.005 | 0.113 | Squalene epoxidase inhibitor | 0.101 0.005 CID_785 0.113 0.004 CID_289 | CID_289 | |
| 0.115 | 0.019 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.118 0.018 CID_785 0.115 0.019 CID_289 | CID_785 | |
| 0.108 | 0.012 | 0.108 | 5 Hydroxytryptamine 3 agonist | 0.106 0.013 CID_785 0.092 0.019 CID_289 | ||
| 0.121 | 0.024 | 0.128 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.128 0.021 CID_785 0.104 0.035 CID_289 | CID_785 | |
| 0.273 | 0.177 | 0.324 | DNA directed DNA polymerase inhibitor | 0.271 0.178 CID_785 0.324 0.15 CID_289 | CID_289 | |
| 0.104 | 0.008 | 0.106 | Exportin-1 inhibitor | 0.106 0.007 CID_785 0.099 0.01 CID_289 | CID_785 | |
| 0.145 | 0.049 | 0.148 | Proteasome inhibitor | 0.144 0.05 CID_785 0.148 0.048 CID_289 | CID_289 | |
| 0.109 | 0.013 | 0.109 | NMDA receptor glycine site agonist | 0.109 0.013 CID_785 0.109 0.013 CID_289 | ||
| 0.1 | 0.005 | 0.105 | CXC chemokine 1 receptor antagonist | 0.105 0.005 CID_785 0.095 0.006 CID_289 | CID_785 | |
| 0.177 | 0.083 | 0.192 | P-glycoprotein inhibitor | 0.176 0.084 CID_785 0.192 0.069 CID_289 | CID_289 | |
| 0.107 | 0.014 | 0.11 | Beta adrenoreceptor antagonist | 0.108 0.014 CID_785 0.11 0.013 CID_289 | CID_289 | |
| 0.103 | 0.01 | 0.188 | Dopamine D2 agonist | 0.112 0.009 CID_785 0.188 0.005 CID_289 | CID_289 | |
| 0.099 | 0.006 | 0.103 | Alpha-mannosidase inhibitor | 0.103 0.006 CID_785 0.094 0.007 CID_289 | CID_785 | |
| 0.105 | 0.013 | 0.105 | Vanilloid 4 agonist | 0.105 0.014 CID_785 0.105 0.013 CID_289 | ||
| 0.113 | 0.021 | 0.127 | Dopamine D1 antagonist | 0.109 0.022 CID_785 0.127 0.018 CID_289 | CID_289 | |
| 0.104 | 0.012 | 0.104 | Protein kinase C beta inhibitor | 0.102 0.013 CID_785 0.099 0.014 CID_289 | ||
| 0.155 | 0.064 | 0.163 | Thiol protease inhibitor | 0.153 0.066 CID_785 0.163 0.059 CID_289 | CID_289 | |
| 0.236 | 0.144 | 0.313 | Thioredoxin glutathione reductase inhibitor | 0.23 0.148 CID_785 0.313 0.095 CID_289 | CID_289 | |
| 0.271 | 0.18 | 0.318 | DNA polymerase beta inhibitor | 0.265 0.183 CID_785 0.318 0.156 CID_289 | CID_289 | |
| 0.148 | 0.058 | 0.148 | Nav1.2 sodium channel blocker | 0.143 0.062 CID_785 0.127 0.075 CID_289 | ||
| 0.101 | 0.011 | 0.107 | Fatty acid synthase inhibitor | 0.105 0.01 CID_785 0.107 0.009 CID_289 | CID_289 | |
| 0.099 | 0.009 | 0.101 | CD45 antagonist | 0.09 0.01 CID_785 0.101 0.009 CID_289 | CID_289 | |
| 0.1 | 0.011 | 0.103 | Carbonic anhydrase XIV inhibitor | 0.103 0.01 CID_785 0.1 0.011 CID_289 | CID_785 | |
| 0.108 | 0.02 | 0.111 | Aromatase inhibitor | 0.111 0.019 CID_785 0.094 0.023 CID_289 | CID_785 | |
| 0.093 | 0.006 | 0.105 | Fumarate hydratase inhibitor | 0.105 0.005 CID_785 0.093 0.006 CID_289 | CID_785 | |
| 0.095 | 0.008 | 0.097 | Transcription factor RelA inhibitor | 0.096 0.008 CID_785 0.097 0.007 CID_289 | CID_289 | |
| 0.094 | 0.006 | 0.096 | Mannosidase inhibitor | 0.096 0.006 CID_785 0.088 0.007 CID_289 | CID_785 | |
| 0.091 | 0.004 | 0.091 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.089 0.004 CID_785 0.082 0.004 CID_289 | ||
| 0.168 | 0.082 | 0.168 | LIM domain kinase 1 inhibitor | 0.165 0.084 CID_785 0.158 0.09 CID_289 | ||
| 0.108 | 0.023 | 0.108 | Thioredoxin reductase inhibitor | 0.108 0.023 CID_785 0.105 0.024 CID_289 | ||
| 0.089 | 0.006 | 0.107 | Adenine nucleotide translocase inhibitor | 0.093 0.005 CID_785 0.107 0.004 CID_289 | CID_289 | |
| 0.087 | 0.005 | 0.09 | Pregnane X receptor antagonist | 0.09 0.004 CID_785 0.087 0.005 CID_289 | CID_785 | |
| 0.1 | 0.017 | 0.1 | Protein kinase C eta inhibitor | 0.098 0.018 CID_785 0.076 0.026 CID_289 | ||
| 0.092 | 0.01 | 0.099 | Sphingosine kinase inhibitor | 0.096 0.009 CID_785 0.099 0.008 CID_289 | CID_289 | |
| 0.087 | 0.005 | 0.087 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.087 0.005 CID_785 0.076 0.005 CID_289 | ||
| 0.142 | 0.061 | 0.171 | M17 leucyl aminopeptidase inhibitor | 0.148 0.057 CID_785 0.171 0.044 CID_289 | CID_289 | |
| 0.087 | 0.005 | 0.089 | Nicotinic acid receptor agonist | 0.089 0.005 CID_785 0.063 0.01 CID_289 | CID_785 | |
| 0.106 | 0.024 | 0.107 | Interferon agonist | 0.107 0.024 CID_785 0.103 0.026 CID_289 | CID_785 | |
| 0.086 | 0.005 | 0.094 | Dihydropteroate synthase inhibitor | 0.094 0.005 CID_785 0.07 0.008 CID_289 | CID_785 | |
| 0.218 | 0.137 | 0.304 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.202 0.154 CID_785 0.304 0.061 CID_289 | CID_289 | |
| 0.122 | 0.041 | 0.127 | Gastric antisecretory | 0.118 0.044 CID_785 0.127 0.038 CID_289 | CID_289 | |
| 0.096 | 0.016 | 0.096 | 5 Hydroxytryptamine 2A agonist | 0.096 0.016 CID_785 0.081 0.026 CID_289 | ||
| 0.166 | 0.085 | 0.179 | Lipocortins synthesis antagonist | 0.179 0.072 CID_785 0.166 0.085 CID_289 | CID_785 | |
| 0.105 | 0.025 | 0.112 | Lipase inhibitor | 0.109 0.023 CID_785 0.112 0.021 CID_289 | CID_289 | |
| 0.15 | 0.071 | 0.157 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.148 0.076 CID_785 0.157 0.06 CID_289 | CID_289 | |
| 0.145 | 0.066 | 0.145 | Toll-Like receptor 9 antagonist | 0.145 0.066 CID_785 0.14 0.07 CID_289 | ||
| 0.096 | 0.017 | 0.105 | Ornithine carbamoyltransferase inhibitor | 0.105 0.015 CID_785 0.096 0.017 CID_289 | CID_785 | |
| 0.09 | 0.013 | 0.093 | Beta 1 adrenoreceptor antagonist | 0.091 0.013 CID_785 0.093 0.012 CID_289 | CID_289 | |
| 0.084 | 0.007 | 0.084 | Beta 2 adrenoreceptor agonist | 0.084 0.007 CID_785 0.084 0.007 CID_289 | ||
| 0.102 | 0.026 | 0.104 | Caspase 7 inhibitor | 0.102 0.026 CID_785 0.104 0.025 CID_289 | CID_289 | |
| 0.258 | 0.181 | 0.264 | Transcription factor inhibitor | 0.25 0.187 CID_785 0.264 0.177 CID_289 | CID_289 | |
| 0.133 | 0.056 | 0.133 | Acetylcholine muscarinic antagonist | 0.13 0.058 CID_785 0.125 0.062 CID_289 | ||
| 0.08 | 0.004 | 0.08 | Glutamate (mGluR1a) agonist | 0.08 0.004 CID_785 0.055 0.005 CID_289 | ||
| 0.088 | 0.012 | 0.088 | Glucosylceramidase inhibitor | 0.088 0.012 CID_785 0.088 0.012 CID_289 | ||
| 0.082 | 0.006 | 0.082 | Purinergic P2X4 antagonist | 0.078 0.007 CID_785 0.075 0.008 CID_289 | ||
| 0.093 | 0.017 | 0.093 | Aryl hydrocarbon receptor antagonist | 0.093 0.017 CID_785 0.088 0.02 CID_289 | ||
| 0.13 | 0.056 | 0.141 | Protein kinase (CK2) alpha inhibitor | 0.132 0.053 CID_785 0.141 0.047 CID_289 | CID_289 | |
| 0.144 | 0.07 | 0.144 | MAP3K9 inhibitor | 0.139 0.077 CID_785 | ||
| 0.08 | 0.006 | 0.08 | Immunoglobulin Fc receptor antagonist | 0.078 0.007 CID_785 0.074 0.009 CID_289 | ||
| 0.087 | 0.013 | 0.087 | Cyclin D1 inhibitor | 0.086 0.013 CID_785 0.083 0.015 CID_289 | ||
| 0.085 | 0.011 | 0.085 | Calcium channel P-type blocker | 0.083 0.012 CID_785 0.085 0.011 CID_289 | ||
| 0.153 | 0.08 | 0.205 | Thrombolytic | 0.161 0.074 CID_785 0.205 0.05 CID_289 | CID_289 | |
| 0.083 | 0.011 | 0.085 | Beta 2 adrenoreceptor antagonist | 0.084 0.01 CID_785 0.085 0.01 CID_289 | CID_289 | |
| 0.09 | 0.018 | 0.099 | Alpha 2 adrenoreceptor agonist | 0.088 0.019 CID_785 0.099 0.015 CID_289 | CID_289 | |
| 0.12 | 0.048 | 0.133 | Protein kinase (CK2) inhibitor | 0.123 0.046 CID_785 0.133 0.041 CID_289 | CID_289 | |
| 0.091 | 0.019 | 0.114 | Neuraminidase (influenza) inhibitor | 0.114 0.013 CID_785 0.11 0.014 CID_289 | CID_785 | |
| 0.076 | 0.004 | 0.084 | Glutamate (mGluR8) agonist | 0.081 0.004 CID_785 0.084 0.004 CID_289 | CID_289 | |
| 0.125 | 0.054 | 0.135 | Alpha 2b adrenoreceptor antagonist | 0.121 0.058 CID_785 0.135 0.047 CID_289 | CID_289 | |
| 0.091 | 0.02 | 0.091 | Potassium channel (ATP-sensitive) blocker | 0.088 0.022 CID_785 0.09 0.021 CID_289 | ||
| 0.217 | 0.147 | 0.234 | Thyroid hormone antagonist | 0.216 0.148 CID_785 0.234 0.134 CID_289 | CID_289 | |
| 0.085 | 0.014 | 0.085 | Sphingosine 1-phosphate receptor 3 antagonist | 0.084 0.014 CID_785 0.075 0.021 CID_289 | ||
| 0.136 | 0.066 | 0.154 | Toll-Like receptor antagonist | 0.141 0.062 CID_785 0.154 0.053 CID_289 | CID_289 | |
| 0.104 | 0.034 | 0.112 | Inducible nitric-oxide synthase inhibitor | 0.106 0.032 CID_785 0.112 0.028 CID_289 | CID_289 | |
| 0.075 | 0.006 | 0.075 | GABA uptake inhibitor | 0.072 0.006 CID_785 0.075 0.006 CID_289 | ||
| 0.145 | 0.076 | 0.153 | MAP kinase 3 inhibitor | 0.146 0.073 CID_785 0.153 0.063 CID_289 | CID_289 | |
| 0.082 | 0.014 | 0.084 | Heme oxygenase stimulant | 0.084 0.013 CID_785 0.082 0.014 CID_289 | CID_785 | |
| 0.08 | 0.012 | 0.08 | Potassium channel Kv1.3 blocker | 0.077 0.013 CID_785 0.073 0.014 CID_289 | ||
| 0.079 | 0.011 | 0.106 | Glucose-6-phosphate translocase inhibitor | 0.084 0.01 CID_785 0.106 0.005 CID_289 | CID_289 | |
| 0.087 | 0.019 | 0.088 | Interferon inducer | 0.088 0.018 CID_785 0.085 0.02 CID_289 | CID_785 | |
| 0.074 | 0.006 | 0.075 | Geranyltranstransferase inhibitor | 0.075 0.006 CID_785 0.073 0.006 CID_289 | CID_785 | |
| 0.072 | 0.004 | 0.072 | Guanylate cyclase inhibitor | 0.072 0.004 CID_785 0.071 0.005 CID_289 | ||
| 0.178 | 0.111 | 0.193 | Hypolipemic | 0.193 0.099 CID_785 0.157 0.13 CID_289 | CID_785 | |
| 0.074 | 0.007 | 0.084 | Opioid delta receptor agonist | 0.084 0.006 CID_785 0.032 0.031 CID_289 | CID_785 | |
| 0.071 | 0.004 | 0.075 | Kainate receptor agonist | 0.075 0.004 CID_785 0.071 0.004 CID_289 | CID_785 | |
| 0.083 | 0.017 | 0.085 | MDM2 inhibitor | 0.082 0.017 CID_785 0.085 0.015 CID_289 | CID_289 | |
| 0.098 | 0.032 | 0.1 | Nicotinic alpha4beta2 receptor antagonist | 0.1 0.031 CID_785 0.097 0.034 CID_289 | CID_785 | |
| 0.121 | 0.056 | 0.121 | GABA receptor agonist | 0.118 0.058 CID_785 0.12 0.056 CID_289 | ||
| 0.071 | 0.006 | 0.071 | Glutamate (mGluR3) antagonist | 0.071 0.006 CID_785 0.063 0.007 CID_289 | ||
| 0.078 | 0.013 | 0.081 | Carbonic anhydrase VII inhibitor | 0.081 0.013 CID_785 0.079 0.013 CID_289 | CID_785 | |
| 0.091 | 0.026 | 0.092 | Acetylcholine M5 receptor agonist | 0.092 0.025 CID_785 0.091 0.026 CID_289 | CID_785 | |
| 0.069 | 0.004 | 0.071 | ATP citrate lysase inhibitor | 0.071 0.004 CID_785 0.066 0.005 CID_289 | CID_785 | |
| 0.078 | 0.013 | 0.081 | Epithelial sodium channel blocker | 0.081 0.012 CID_785 0.072 0.016 CID_289 | CID_785 | |
| 0.187 | 0.122 | 0.203 | MAP-kinase-activated kinase 5 inhibitor | 0.191 0.115 CID_785 0.203 0.099 CID_289 | CID_289 | |
| 0.102 | 0.038 | 0.106 | Bromodomain-containing protein 2 inhibitor | 0.106 0.033 CID_785 0.101 0.039 CID_289 | CID_785 | |
| 0.087 | 0.022 | 0.087 | Protease 3C (Human rhinovirus) inhibitor | 0.086 0.023 CID_785 0.079 0.028 CID_289 | ||
| 0.129 | 0.066 | 0.129 | Glutamate receptor antagonist | 0.129 0.066 CID_785 | ||
| 0.072 | 0.009 | 0.083 | Estrogen-related receptor alpha antagonist | 0.083 0.008 CID_785 0.03 0.026 CID_289 | CID_785 | |
| 0.079 | 0.017 | 0.084 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 CID_785 0.084 0.015 CID_289 | CID_289 | |
| 0.064 | 0.002 | 0.064 | Estrogen-related receptor gamma antagonist | 0.063 0.002 CID_785 0.056 0.003 CID_289 | ||
| 0.092 | 0.031 | 0.101 | Alpha adrenoreceptor agonist | 0.088 0.033 CID_785 0.101 0.028 CID_289 | CID_289 | |
| 0.066 | 0.005 | 0.066 | Uridine phosphorylase inhibitor | 0.065 0.005 CID_785 0.066 0.005 CID_289 | ||
| 0.142 | 0.081 | 0.157 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.157 0.068 CID_785 | CID_785 | |
| 0.075 | 0.014 | 0.078 | Glutamate (mGluR group III) agonist | 0.071 0.015 CID_785 0.078 0.013 CID_289 | CID_289 | |
| 0.07 | 0.009 | 0.077 | Phosphoglycerate kinase inhibitor | 0.075 0.009 CID_785 0.077 0.009 CID_289 | CID_289 | |
| 0.072 | 0.012 | 0.072 | Leukotriene C antagonist | 0.072 0.013 CID_785 0.072 0.012 CID_289 | ||
| 0.073 | 0.013 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.074 0.012 CID_785 0.073 0.013 CID_289 | CID_785 | |
| 0.072 | 0.013 | 0.125 | Vanilloid 2 antagonist | 0.077 0.01 CID_785 0.125 0.004 CID_289 | CID_289 | |
| 0.075 | 0.015 | 0.075 | 5 Hydroxytryptamine 7 agonist | 0.074 0.017 CID_785 0.065 0.025 CID_289 | ||
| 0.1 | 0.04 | 0.127 | ATPase (Vacuolar H+) inhibitor | 0.1 0.04 CID_785 0.127 0.015 CID_289 | CID_289 | |
| 0.063 | 0.004 | 0.063 | CF transmembrane conductance regulator antagonist | 0.063 0.004 CID_785 0.062 0.004 CID_289 | ||
| 0.144 | 0.085 | 0.151 | Cyclin-dependent kinase 8 inhibitor | 0.151 0.079 CID_785 0.147 0.082 CID_289 | CID_785 | |
| 0.072 | 0.014 | 0.135 | Dopamine D5 antagonist | 0.076 0.013 CID_785 0.135 0.007 CID_289 | CID_289 | |
| 0.068 | 0.01 | 0.068 | Glutamate (mGluR group III) antagonist | 0.067 0.01 CID_785 0.062 0.012 CID_289 | ||
| 0.113 | 0.055 | 0.12 | Alpha 2c adrenoreceptor antagonist | 0.108 0.059 CID_785 0.12 0.05 CID_289 | CID_289 | |
| 0.068 | 0.011 | 0.069 | Oxytocin agonist | 0.069 0.01 CID_785 0.064 0.013 CID_289 | CID_785 | |
| 0.091 | 0.034 | 0.107 | Purinergic P2X2 antagonist | 0.107 0.027 CID_785 | CID_785 | |
| 0.071 | 0.014 | 0.082 | Opioid kappa receptor agonist | 0.082 0.012 CID_785 | CID_785 | |
| 0.088 | 0.032 | 0.09 | Amidase inhibitor | 0.086 0.033 CID_785 0.09 0.03 CID_289 | CID_289 | |
| 0.067 | 0.011 | 0.068 | Glutamate (mGluR4) antagonist | 0.068 0.011 CID_785 0.063 0.013 CID_289 | CID_785 | |
| 0.133 | 0.077 | 0.134 | Histone deacetylase SIRT1 inhibitor | 0.134 0.076 CID_785 0.13 0.08 CID_289 | CID_785 | |
| 0.081 | 0.025 | 0.087 | Carbonic anhydrase stimulant | 0.083 0.024 CID_785 0.087 0.023 CID_289 | CID_289 | |
| 0.066 | 0.01 | 0.066 | Liver X receptor alpha agonist | 0.064 0.011 CID_785 0.066 0.01 CID_289 | ||
| 0.125 | 0.069 | 0.125 | Nav1.3 sodium channel blocker | 0.121 0.072 CID_785 0.109 0.086 CID_289 | ||
| 0.088 | 0.033 | 0.088 | Sphingosine 1-phosphate receptor antagonist | 0.088 0.032 CID_785 0.079 0.047 CID_289 | ||
| 0.102 | 0.046 | 0.105 | Potassium channel activator | 0.105 0.043 CID_785 0.104 0.044 CID_289 | CID_785 | |
| 0.059 | 0.004 | 0.061 | Glutamate (mGluR3) agonist | 0.061 0.004 CID_785 0.054 0.004 CID_289 | CID_785 | |
| 0.106 | 0.051 | 0.114 | Nitric-oxide synthase inhibitor | 0.108 0.048 CID_785 0.114 0.042 CID_289 | CID_289 | |
| 0.074 | 0.019 | 0.074 | Glycine transporter 2 inhibitor | 0.072 0.02 CID_785 0.048 0.032 CID_289 | ||
| 0.059 | 0.005 | 0.059 | Vanilloid 3 antagonist | 0.058 0.005 CID_785 0.059 0.005 CID_289 | ||
| 0.077 | 0.022 | 0.078 | Phosphodiesterase 1C inhibitor | 0.077 0.021 CID_785 0.078 0.021 CID_289 | CID_289 | |
| 0.071 | 0.017 | 0.071 | Nicotinic alpha3beta2 receptor antagonist | 0.07 0.018 CID_785 0.071 0.017 CID_289 | ||
| 0.059 | 0.005 | 0.061 | Protein kinase (CK2) beta inhibitor | 0.061 0.005 CID_785 0.06 0.005 CID_289 | CID_785 | |
| 0.068 | 0.014 | 0.07 | Adenosine deaminase inhibitor | 0.07 0.014 CID_785 0.068 0.014 CID_289 | CID_785 | |
| 0.072 | 0.018 | 0.137 | Plasminogen activator inhibitor antagonist | 0.075 0.017 CID_785 0.137 0.005 CID_289 | CID_289 | |
| 0.115 | 0.061 | 0.116 | Nav1.5 sodium channel blocker | 0.116 0.06 CID_785 0.114 0.062 CID_289 | CID_785 | |
| 0.079 | 0.026 | 0.079 | Acetylcholine M3 receptor antagonist | 0.077 0.027 CID_785 0.065 0.035 CID_289 | ||
| 0.079 | 0.026 | 0.079 | TRPA1 antagonist | 0.079 0.026 CID_785 0.07 0.033 CID_289 | ||
| 0.062 | 0.009 | 0.07 | Nerve growth factor antagonist | 0.061 0.009 CID_785 0.07 0.005 CID_289 | CID_289 | |
| 0.063 | 0.011 | 0.063 | GABA B receptor antagonist | 0.063 0.011 CID_785 0.062 0.011 CID_289 | ||
| 0.086 | 0.033 | 0.088 | Phosphodiesterase VI inhibitor | 0.087 0.032 CID_785 0.088 0.03 CID_289 | CID_289 | |
| 0.099 | 0.046 | 0.1 | Phosphodiesterase I inhibitor | 0.1 0.044 CID_785 0.097 0.048 CID_289 | CID_785 | |
| 0.082 | 0.03 | 0.085 | Leukotriene antagonist | 0.081 0.031 CID_785 0.085 0.029 CID_289 | CID_289 | |
| 0.066 | 0.014 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | 0.067 0.014 CID_785 0.061 0.017 CID_289 | CID_785 | |
| 0.065 | 0.014 | 0.07 | Factor III inhibitor | 0.07 0.01 CID_785 0.062 0.016 CID_289 | CID_785 | |
| 0.064 | 0.013 | 0.064 | Urate transporter 1 inhibitor | 0.064 0.013 CID_785 0.058 0.015 CID_289 | ||
| 0.064 | 0.012 | 0.068 | AICAR transformylase inhibitor | 0.068 0.01 CID_785 0.058 0.015 CID_289 | CID_785 | |
| 0.098 | 0.047 | 0.102 | Aminoacyl-tRNA synthetase inhibitor | 0.102 0.043 CID_785 0.084 0.069 CID_289 | CID_785 | |
| 0.057 | 0.006 | 0.057 | Liver X receptor beta antagonist | 0.055 0.007 CID_785 0.049 0.009 CID_289 | ||
| 0.077 | 0.027 | 0.094 | Neuraminidase inhibitor | 0.092 0.018 CID_785 0.094 0.018 CID_289 | CID_289 | |
| 0.065 | 0.016 | 0.066 | Heparanase inhibitor | 0.066 0.015 CID_785 0.063 0.019 CID_289 | CID_785 | |
| 0.086 | 0.036 | 0.086 | Adenosine A3 receptor antagonist | 0.085 0.037 CID_785 0.081 0.042 CID_289 | ||
| 0.058 | 0.009 | 0.059 | Beta adrenoreceptor agonist | 0.059 0.009 CID_785 0.058 0.009 CID_289 | CID_785 | |
| 0.098 | 0.049 | 0.098 | Calcium antagonist | 0.094 0.052 CID_785 0.098 0.049 CID_289 | ||
| 0.073 | 0.024 | 0.073 | Potassium channel intermediate-conductance Ca-activated blocker | 0.069 0.027 CID_785 0.073 0.024 CID_289 | ||
| 0.057 | 0.008 | 0.057 | Heme oxygenase inhibitor | 0.056 0.008 CID_785 0.057 0.008 CID_289 | ||
| 0.077 | 0.028 | 0.079 | Ribonucleotide reductase inhibitor | 0.079 0.027 CID_785 0.074 0.029 CID_289 | CID_785 | |
| 0.121 | 0.073 | 0.121 | Cholinergic antagonist | 0.12 0.074 CID_785 0.113 0.081 CID_289 | ||
| 0.075 | 0.027 | 0.077 | Ribonucleoside-diphosphate reductase inhibitor | 0.077 0.026 CID_785 0.072 0.028 CID_289 | CID_785 | |
| 0.063 | 0.015 | 0.068 | Cholesterol esterase inhibitor | 0.062 0.015 CID_785 0.068 0.011 CID_289 | CID_289 | |
| 0.082 | 0.034 | 0.083 | Secretase beta inhibitor | 0.083 0.032 CID_785 0.081 0.035 CID_289 | CID_785 | |
| 0.053 | 0.006 | 0.057 | Sodium/glucose cotransporter 2 inhibitor | 0.057 0.005 CID_785 0.047 0.007 CID_289 | CID_785 | |
| 0.081 | 0.034 | 0.084 | Carbonic anhydrase inhibitor | 0.084 0.033 CID_785 0.079 0.035 CID_289 | CID_785 | |
| 0.058 | 0.011 | 0.062 | Arginase inhibitor | 0.062 0.01 CID_785 0.06 0.01 CID_289 | CID_785 | |
| 0.111 | 0.064 | 0.111 | DNA intercalator | 0.107 0.067 CID_785 0.105 0.069 CID_289 | ||
| 0.161 | 0.114 | 0.164 | Focal adhesion kinase 2 inhibitor | 0.159 0.116 CID_785 0.164 0.109 CID_289 | CID_289 | |
| 0.067 | 0.02 | 0.071 | Lysine-specific demethylase 1A inhibitor | 0.066 0.021 CID_785 0.071 0.017 CID_289 | CID_289 | |
| 0.059 | 0.014 | 0.059 | Cytokine production stimulant | 0.059 0.014 CID_785 0.057 0.016 CID_289 | ||
| 0.067 | 0.021 | 0.07 | Leukotriene B4 antagonist | 0.066 0.022 CID_785 0.07 0.019 CID_289 | CID_289 | |
| 0.063 | 0.017 | 0.066 | Potassium channel (Inward rectifier) activator | 0.066 0.014 CID_785 0.062 0.018 CID_289 | CID_785 | |
| 0.048 | 0.003 | 0.048 | Nicotinic acid receptor 1 antagonist | 0.048 0.003 CID_785 0.039 0.003 CID_289 | ||
| 0.117 | 0.073 | 0.117 | Acetylcholine antagonist | 0.116 0.074 CID_785 0.109 0.081 CID_289 | ||
| 0.066 | 0.021 | 0.066 | DNA helicase inhibitor | 0.064 0.022 CID_785 0.066 0.021 CID_289 | ||
| 0.199 | 0.154 | 0.214 | Thyroid hormone beta antagonist | 0.198 0.156 CID_785 0.214 0.142 CID_289 | CID_289 | |
| 0.056 | 0.012 | 0.059 | AMPA 4 receptor antagonist | 0.059 0.01 CID_785 0.049 0.016 CID_289 | CID_785 | |
| 0.056 | 0.012 | 0.062 | Sphingosine kinase 1 inhibitor | 0.058 0.01 CID_785 0.062 0.008 CID_289 | CID_289 | |
| 0.061 | 0.017 | 0.063 | Thymidylate synthase inhibitor | 0.063 0.015 CID_785 0.055 0.022 CID_289 | CID_785 | |
| 0.093 | 0.049 | 0.107 | Antineoplastic antibiotic | 0.107 0.043 CID_785 0.094 0.049 CID_289 | CID_785 | |
| 0.048 | 0.005 | 0.052 | Thyroid hormone agonist | 0.052 0.004 CID_785 0.046 0.005 CID_289 | CID_785 | |
| 0.049 | 0.006 | 0.049 | CXC chemokine 2 receptor antagonist | 0.047 0.006 CID_785 0.043 0.007 CID_289 | ||
| 0.047 | 0.004 | 0.057 | Alpha 2a adrenoreceptor agonist | 0.045 0.004 CID_785 0.057 0.004 CID_289 | CID_289 | |
| 0.06 | 0.017 | 0.074 | Dihydroorotase inhibitor | 0.06 0.016 CID_785 0.074 0.01 CID_289 | CID_289 | |
| 0.059 | 0.016 | 0.063 | Potassium channel (ATP-sensitive) activator | 0.063 0.014 CID_785 0.058 0.018 CID_289 | CID_785 | |
| 0.079 | 0.037 | 0.08 | Potassium channel (Tandem pore domain) blocker | 0.079 0.038 CID_785 0.08 0.034 CID_289 | CID_289 | |
| 0.07 | 0.028 | 0.07 | Histone deacetylase SIRT3 inhibitor | 0.07 0.028 CID_785 0.064 0.039 CID_289 | ||
| 0.052 | 0.01 | 0.052 | Delayed rectifier potassium channel blocker | 0.052 0.01 CID_785 0.047 0.013 CID_289 | ||
| 0.08 | 0.038 | 0.083 | Cyclin B3 inhibitor | 0.083 0.036 CID_785 0.081 0.038 CID_289 | CID_785 | |
| 0.096 | 0.055 | 0.1 | ABCA1 expression enhancer | 0.1 0.051 CID_785 0.093 0.061 CID_289 | CID_785 | |
| 0.05 | 0.009 | 0.05 | Free fatty acid receptor 1 antagonist | 0.048 0.01 CID_785 0.05 0.009 CID_289 | ||
| 0.083 | 0.042 | 0.087 | Metalloproteinase-9 inhibitor | 0.083 0.042 CID_785 0.087 0.039 CID_289 | CID_289 | |
| 0.053 | 0.013 | 0.058 | Retinoid X alpha receptor agonist | 0.058 0.012 CID_785 0.053 0.013 CID_289 | CID_785 | |
| 0.056 | 0.015 | 0.056 | Thymidine kinase inhibitor | 0.055 0.016 CID_785 0.055 0.016 CID_289 | ||
| 0.045 | 0.005 | 0.045 | Prostaglandin F2 alpha agonist | 0.045 0.005 CID_785 0.042 0.005 CID_289 | ||
| 0.064 | 0.025 | 0.068 | Dihydroorotate dehydrogenase inhibitor | 0.063 0.026 CID_785 0.068 0.023 CID_289 | CID_289 | |
| 0.069 | 0.029 | 0.07 | Carbonic anhydrase XII inhibitor | 0.07 0.029 CID_785 0.067 0.03 CID_289 | CID_785 | |
| 0.044 | 0.004 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.045 0.004 CID_785 0.039 0.005 CID_289 | CID_785 | |
| 0.043 | 0.004 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 CID_785 0.043 0.004 CID_289 | CID_785 | |
| 0.048 | 0.009 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.049 0.008 CID_785 0.046 0.01 CID_289 | CID_785 | |
| 0.063 | 0.024 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.024 CID_785 0.056 0.038 CID_289 | CID_785 | |
| 0.111 | 0.072 | 0.111 | Sphingosine 1-phosphate receptor 2 agonist | 0.107 0.083 CID_785 | ||
| 0.044 | 0.005 | 0.102 | Dopamine D1 agonist | 0.051 0.005 CID_785 0.102 0.003 CID_289 | CID_289 | |
| 0.055 | 0.016 | 0.06 | Retinoid X receptor agonist | 0.06 0.014 CID_785 0.055 0.016 CID_289 | CID_785 | |
| 0.051 | 0.013 | 0.051 | RNA-directed RNA polymerase inhibitor | 0.051 0.012 CID_785 0.042 0.017 CID_289 | ||
| 0.043 | 0.005 | 0.045 | Purinergic P2Y15 antagonist | 0.045 0.005 CID_785 0.043 0.005 CID_289 | CID_785 | |
| 0.069 | 0.03 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.03 CID_785 0.069 0.03 CID_289 | ||
| 0.043 | 0.006 | 0.045 | Sodium/glucose cotransporter inhibitor | 0.045 0.006 CID_785 0.039 0.007 CID_289 | CID_785 | |
| 0.121 | 0.084 | 0.121 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.086 CID_785 0.12 0.084 CID_289 | ||
| 0.076 | 0.039 | 0.078 | Sirtuin 1 inhibitor | 0.078 0.037 CID_785 0.072 0.042 CID_289 | CID_785 | |
| 0.04 | 0.003 | 0.04 | Estrogen-related receptor gamma agonist | 0.039 0.003 CID_785 0.036 0.003 CID_289 | ||
| 0.048 | 0.012 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 CID_785 0.047 0.013 CID_289 | ||
| 0.068 | 0.032 | 0.068 | Acetylcholine M5 receptor antagonist | 0.068 0.033 CID_785 0.067 0.033 CID_289 | ||
| 0.041 | 0.004 | 0.041 | Hedgehog signaling activator | 0.041 0.004 CID_785 0.041 0.004 CID_289 | ||
| 0.049 | 0.013 | 0.051 | Retinoid X receptor antagonist | 0.051 0.012 CID_785 0.051 0.012 CID_289 | CID_289 | |
| 0.123 | 0.087 | 0.132 | Cytokine production inhibitor | 0.119 0.09 CID_785 0.132 0.078 CID_289 | CID_289 | |
| 0.06 | 0.024 | 0.063 | Prolyl endopeptidase inhibitor | 0.059 0.025 CID_785 0.063 0.021 CID_289 | CID_289 | |
| 0.068 | 0.033 | 0.07 | Carbonic anhydrase IX inhibitor | 0.07 0.032 CID_785 0.065 0.035 CID_289 | CID_785 | |
| 0.049 | 0.013 | 0.049 | Sirtuin 2 inhibitor | 0.046 0.014 CID_785 0.049 0.013 CID_289 | ||
| 0.045 | 0.01 | 0.056 | Lysophosphatidic acid 2 receptor antagonist | 0.047 0.009 CID_785 0.056 0.007 CID_289 | CID_289 | |
| 0.076 | 0.041 | 0.076 | Peroxisome proliferator-activated receptor gamma antagonist | 0.075 0.042 CID_785 0.075 0.043 CID_289 | ||
| 0.105 | 0.07 | 0.113 | Multidrug resistance-associated protein 1 inhibitor | 0.103 0.073 CID_785 0.113 0.058 CID_289 | CID_289 | |
| 0.06 | 0.025 | 0.06 | Phosphorylase inhibitor | 0.06 0.025 CID_785 0.057 0.026 CID_289 | ||
| 0.043 | 0.009 | 0.043 | Dopamine autoreceptor agonist | 0.041 0.009 CID_785 0.027 0.015 CID_289 | ||
| 0.04 | 0.005 | 0.04 | Glutamate (mGluR1) agonist | 0.039 0.005 CID_785 0.033 0.008 CID_289 | ||
| 0.043 | 0.008 | 0.046 | Nicotinic alpha3beta4 receptor agonist | 0.046 0.007 CID_785 0.038 0.012 CID_289 | CID_785 | |
| 0.124 | 0.091 | 0.125 | Activin receptor-like kinase 2 inhibitor | 0.125 0.091 CID_785 0.125 0.09 CID_289 | CID_289 | |
| 0.06 | 0.027 | 0.061 | Thromboxane synthase inhibitor | 0.061 0.026 CID_785 0.061 0.026 CID_289 | CID_289 | |
| 0.049 | 0.015 | 0.049 | Diamine oxidase inhibitor | 0.047 0.016 CID_785 0.047 0.017 CID_289 | ||
| 0.045 | 0.012 | 0.046 | HCV NS5B polymerase inhibitor | 0.046 0.011 CID_785 0.036 0.017 CID_289 | CID_785 | |
| 0.083 | 0.05 | 0.086 | Metalloproteinase-2 inhibitor | 0.083 0.05 CID_785 0.086 0.047 CID_289 | CID_289 | |
| 0.065 | 0.033 | 0.066 | Prolactin release inhibitor | 0.066 0.031 CID_785 0.065 0.033 CID_289 | CID_785 | |
| 0.065 | 0.032 | 0.067 | Carbonic anhydrase II inhibitor | 0.067 0.031 CID_785 0.063 0.033 CID_289 | CID_785 | |
| 0.058 | 0.026 | 0.058 | Bombesin 2 receptor antagonist | 0.058 0.025 CID_785 0.051 0.032 CID_289 | ||
| 0.045 | 0.013 | 0.045 | Glutamate (mGluR4) agonist | 0.043 0.014 CID_785 0.042 0.015 CID_289 | ||
| 0.08 | 0.048 | 0.101 | Alpha 2a adrenoreceptor antagonist | 0.077 0.051 CID_785 0.101 0.036 CID_289 | CID_289 | |
| 0.04 | 0.009 | 0.041 | Liver X receptor alpha antagonist | 0.041 0.009 CID_785 0.039 0.009 CID_289 | CID_785 | |
| 0.062 | 0.031 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 CID_785 0.065 0.028 CID_289 | CID_785 | |
| 0.116 | 0.084 | 0.129 | Cyclooxygenase 2 inhibitor | 0.121 0.078 CID_785 0.129 0.071 CID_289 | CID_289 | |
| 0.044 | 0.013 | 0.044 | Liver X receptor beta agonist | 0.042 0.014 CID_785 0.039 0.016 CID_289 | ||
| 0.082 | 0.052 | 0.085 | Acetylcholine nicotinic antagonist | 0.085 0.05 CID_785 0.077 0.058 CID_289 | CID_785 | |
| 0.057 | 0.026 | 0.057 | AMPA receptor antagonist | 0.057 0.027 CID_785 0.046 0.035 CID_289 | ||
| 0.048 | 0.017 | 0.048 | Kinesin antagonist | 0.044 0.019 CID_785 | ||
| 0.048 | 0.017 | 0.048 | Kinesin-like protein 1 inhibitor | 0.044 0.019 CID_785 | ||
| 0.034 | 0.004 | 0.034 | NMDA receptor phencyclidine site antagonist | 0.032 0.004 CID_785 0.024 0.005 CID_289 | ||
| 0.087 | 0.056 | 0.097 | Transcription factor NF kappa B stimulant | 0.091 0.05 CID_785 0.097 0.042 CID_289 | CID_289 | |
| 0.065 | 0.035 | 0.067 | Phosphodiesterase 1B inhibitor | 0.067 0.034 CID_785 0.062 0.039 CID_289 | CID_785 | |
| 0.042 | 0.012 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.012 CID_785 0.044 0.01 CID_289 | CID_289 | |
| 0.053 | 0.023 | 0.055 | Carbonic anhydrase IV inhibitor | 0.055 0.022 CID_785 0.055 0.022 CID_289 | CID_289 | |
| 0.033 | 0.003 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 CID_785 0.031 0.003 CID_289 | ||
| 0.04 | 0.01 | 0.041 | Lysine carboxypeptidase inhibitor | 0.041 0.01 CID_785 0.034 0.013 CID_289 | CID_785 | |
| 0.072 | 0.043 | 0.075 | Neuronal nicotinic receptor antagonist | 0.075 0.041 CID_785 0.065 0.049 CID_289 | CID_785 | |
| 0.046 | 0.016 | 0.047 | Potassium channel Kv1.1 blocker | 0.047 0.015 CID_785 0.043 0.019 CID_289 | CID_785 | |
| 0.045 | 0.016 | 0.053 | Nicotinic acid receptor 2 agonist | 0.053 0.013 CID_785 | CID_785 | |
| 0.047 | 0.018 | 0.05 | Membrane dipeptidase inhibitor | 0.05 0.016 CID_785 0.047 0.018 CID_289 | CID_785 | |
| 0.041 | 0.013 | 0.042 | Liver X receptor antagonist | 0.042 0.013 CID_785 0.039 0.014 CID_289 | CID_785 | |
| 0.033 | 0.005 | 0.033 | Complement factor 1s inhibitor | 0.033 0.005 CID_785 0.031 0.007 CID_289 | ||
| 0.066 | 0.038 | 0.066 | I kappa B kinase 2 inhibitor | 0.066 0.037 CID_785 0.063 0.041 CID_289 | ||
| 0.084 | 0.056 | 0.084 | Histamine H2 receptor antagonist | 0.084 0.057 CID_785 0.083 0.059 CID_289 | ||
| 0.04 | 0.012 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 CID_785 0.04 0.012 CID_289 | CID_785 | |
| 0.073 | 0.045 | 0.08 | Prostaglandin-E synthase inhibitor | 0.071 0.047 CID_785 0.08 0.039 CID_289 | CID_289 | |
| 0.045 | 0.018 | 0.045 | 5 Hydroxytryptamine 2B agonist | 0.045 0.018 CID_785 0.041 0.023 CID_289 | ||
| 0.149 | 0.122 | 0.288 | Antimitotic | 0.161 0.112 CID_785 0.288 0.047 CID_289 | CID_289 | |
| 0.108 | 0.081 | 0.108 | Histone deacetylase class III inhibitor | 0.104 0.086 CID_785 | ||
| 0.041 | 0.014 | 0.042 | Retinoid X alpha receptor antagonist | 0.042 0.012 CID_785 0.042 0.012 CID_289 | CID_289 | |
| 0.049 | 0.022 | 0.05 | CDK5/p25 inhibitor | 0.05 0.021 CID_785 0.042 0.028 CID_289 | CID_785 | |
| 0.048 | 0.022 | 0.048 | Histamine H1 receptor agonist | 0.047 0.024 CID_785 0.048 0.022 CID_289 | ||
| 0.061 | 0.035 | 0.063 | Carbonic anhydrase I inhibitor | 0.063 0.033 CID_785 0.059 0.036 CID_289 | CID_785 | |
| 0.048 | 0.022 | 0.051 | Kainate receptor antagonist | 0.051 0.021 CID_785 0.04 0.029 CID_289 | CID_785 | |
| 0.038 | 0.012 | 0.038 | Protein kinase C beta I inhibitor | 0.037 0.013 CID_785 0.032 0.029 CID_289 | ||
| 0.039 | 0.013 | 0.039 | Methionyl aminopeptidase 1 inhibitor | 0.038 0.014 CID_785 0.034 0.019 CID_289 | ||
| 0.067 | 0.042 | 0.072 | Neutrophil collagenase inhibitor | 0.067 0.043 CID_785 0.072 0.038 CID_289 | CID_289 | |
| 0.064 | 0.039 | 0.064 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.042 CID_785 0.062 0.041 CID_289 | ||
| 0.04 | 0.016 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 CID_785 0.037 0.02 CID_289 | ||
| 0.029 | 0.005 | 0.029 | Ileal bile acid transport inhibitor | 0.029 0.005 CID_785 0.026 0.006 CID_289 | ||
| 0.048 | 0.024 | 0.048 | Histamine H2 receptor agonist | 0.048 0.023 CID_785 0.046 0.025 CID_289 | ||
| 0.038 | 0.014 | 0.038 | Protein kinase C beta II inhibitor | 0.037 0.014 CID_785 | ||
| 0.051 | 0.027 | 0.051 | Oleamide hydrolase inhibitor | 0.047 0.03 CID_785 0.042 0.035 CID_289 | ||
| 0.044 | 0.02 | 0.046 | Farnesoid X receptor agonist | 0.043 0.02 CID_785 0.046 0.017 CID_289 | CID_289 | |
| 0.028 | 0.004 | 0.03 | Telomerase stimulant | 0.03 0.003 CID_785 0.028 0.004 CID_289 | CID_785 | |
| 0.029 | 0.005 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.03 0.004 CID_785 0.026 0.007 CID_289 | CID_785 | |
| 0.029 | 0.006 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 CID_785 0.031 0.005 CID_289 | CID_289 | |
| 0.035 | 0.012 | 0.038 | Nicotinic alpha4beta2 receptor agonist | 0.038 0.009 CID_785 0.032 0.015 CID_289 | CID_785 | |
| 0.044 | 0.021 | 0.047 | 5-Alpha-reductase inhibitor | 0.047 0.02 CID_785 0.043 0.022 CID_289 | CID_785 | |
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 CID_785 0.032 0.009 CID_289 | ||
| 0.047 | 0.023 | 0.049 | Erythropoietin receptor agonist | 0.049 0.022 CID_785 | CID_785 | |
| 0.059 | 0.037 | 0.062 | Alpha 1 adrenoreceptor agonist | 0.057 0.04 CID_785 0.062 0.035 CID_289 | CID_289 | |
| 0.042 | 0.02 | 0.042 | Inosine monophosphate dehydrogenase inhibitor | 0.042 0.02 CID_785 0.039 0.023 CID_289 | ||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.027 0.005 CID_785 0.027 0.005 CID_289 | ||
| 0.057 | 0.035 | 0.061 | Thromboxane antagonist | 0.058 0.034 CID_785 0.061 0.032 CID_289 | CID_289 | |
| 0.051 | 0.028 | 0.052 | Aldosterone antagonist | 0.052 0.027 CID_785 0.051 0.028 CID_289 | CID_785 | |
| 0.084 | 0.062 | 0.101 | Alpha 2 adrenoreceptor antagonist | 0.081 0.065 CID_785 0.101 0.047 CID_289 | CID_289 | |
| 0.03 | 0.008 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 CID_785 0.029 0.009 CID_289 | ||
| 0.061 | 0.04 | 0.061 | Phosphodiesterase 1A inhibitor | 0.061 0.038 CID_785 0.06 0.041 CID_289 | ||
| 0.041 | 0.02 | 0.041 | Integrin alpha2 antagonist | 0.04 0.02 CID_785 0.041 0.02 CID_289 | ||
| 0.082 | 0.061 | 0.082 | GABA A receptor agonist | 0.08 0.063 CID_785 0.076 0.072 CID_289 | ||
| 0.045 | 0.024 | 0.049 | DNA gyrase subunit A inhibitor | 0.049 0.018 CID_785 | CID_785 | |
| 0.042 | 0.021 | 0.042 | MAP3K5 inhibitor | 0.042 0.022 CID_785 0.039 0.027 CID_289 | ||
| 0.054 | 0.033 | 0.059 | Thromboxane A2 antagonist | 0.054 0.032 CID_785 0.059 0.029 CID_289 | CID_289 | |
| 0.041 | 0.021 | 0.044 | Kainate receptor 2 antagonist | 0.044 0.019 CID_785 0.041 0.021 CID_289 | CID_785 | |
| 0.031 | 0.011 | 0.033 | Thymidine phosphorylase inhibitor | 0.033 0.009 CID_785 0.033 0.01 CID_289 | CID_289 | |
| 0.036 | 0.016 | 0.037 | Prostaglandin agonist | 0.037 0.016 CID_785 0.034 0.018 CID_289 | CID_785 | |
| 0.162 | 0.142 | 0.28 | Tumour necrosis factor alpha release inhibitor | 0.18 0.127 CID_785 0.28 0.061 CID_289 | CID_289 | |
| 0.036 | 0.016 | 0.036 | AMPA 3 receptor antagonist | 0.036 0.016 CID_785 0.032 0.019 CID_289 | ||
| 0.06 | 0.041 | 0.066 | Cyclin-dependent kinase 6 inhibitor | 0.066 0.035 CID_785 0.06 0.041 CID_289 | CID_785 | |
| 0.032 | 0.013 | 0.035 | Protocollagen prolyl hydroxylase inhibitor | 0.035 0.01 CID_785 0.031 0.014 CID_289 | CID_785 | |
| 0.059 | 0.04 | 0.059 | Adenosine A1 receptor antagonist | 0.059 0.04 CID_785 0.054 0.045 CID_289 | ||
| 0.024 | 0.006 | 0.025 | Alpha 2b adrenoreceptor agonist | 0.024 0.006 CID_785 0.025 0.005 CID_289 | CID_289 | |
| 0.022 | 0.004 | 0.028 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.023 0.004 CID_785 0.028 0.003 CID_289 | CID_289 | |
| 0.03 | 0.011 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CID_785 0.03 0.011 CID_289 | ||
| 0.028 | 0.009 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.009 CID_785 0.028 0.009 CID_289 | ||
| 0.047 | 0.029 | 0.048 | Purinergic P2Y antagonist | 0.048 0.028 CID_785 0.046 0.03 CID_289 | CID_785 | |
| 0.022 | 0.004 | 0.028 | Glutamate (mGluR6) agonist | 0.025 0.004 CID_785 0.028 0.003 CID_289 | CID_289 | |
| 0.054 | 0.036 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | 0.055 0.034 CID_785 0.05 0.044 CID_289 | CID_785 | |
| 0.036 | 0.018 | 0.036 | Melatonin receptor 1A agonist | 0.036 0.018 CID_785 0.036 0.018 CID_289 | ||
| 0.1 | 0.083 | 0.117 | Electron transport complex I inhibitor | 0.106 0.069 CID_785 0.117 0.05 CID_289 | CID_289 | |
| 0.044 | 0.026 | 0.044 | Angiotensin AT1 receptor antagonist | 0.043 0.028 CID_785 0.04 0.033 CID_289 | ||
| 0.022 | 0.005 | 0.023 | Thromboxane A2 agonist | 0.023 0.004 CID_785 0.022 0.005 CID_289 | CID_785 | |
| 0.023 | 0.006 | 0.029 | Thyroid hormone alpha antagonist | 0.029 0.005 CID_785 0.028 0.005 CID_289 | CID_785 | |
| 0.03 | 0.013 | 0.031 | NMDA receptor glycine site antagonist | 0.031 0.012 CID_785 0.027 0.014 CID_289 | CID_785 | |
| 0.081 | 0.064 | 0.085 | Bcr-Abl kinase inhibitor | 0.085 0.058 CID_785 0.084 0.059 CID_289 | CID_785 | |
| 0.038 | 0.021 | 0.041 | Calcitonin receptor agonist | 0.041 0.02 CID_785 0.032 0.025 CID_289 | CID_785 | |
| 0.047 | 0.03 | 0.053 | Neurotensin receptor antagonist | 0.053 0.026 CID_785 | CID_785 | |
| 0.045 | 0.028 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.027 CID_785 0.044 0.028 CID_289 | ||
| 0.063 | 0.047 | 0.097 | Selectin antagonist | 0.073 0.041 CID_785 0.097 0.029 CID_289 | CID_289 | |
| 0.026 | 0.01 | 0.026 | ICAM 1 antagonist | 0.026 0.01 CID_785 0.026 0.01 CID_289 | ||
| 0.029 | 0.014 | 0.033 | Prostaglandin H2 antagonist | 0.03 0.014 CID_785 0.033 0.01 CID_289 | CID_289 | |
| 0.029 | 0.013 | 0.03 | Prostaglandin EP2 agonist | 0.03 0.012 CID_785 0.025 0.015 CID_289 | CID_785 | |
| 0.054 | 0.038 | 0.054 | GABA receptor antagonist | 0.052 0.041 CID_785 0.051 0.043 CID_289 | ||
| 0.031 | 0.016 | 0.032 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.032 0.015 CID_785 0.028 0.019 CID_289 | CID_785 | |
| 0.057 | 0.041 | 0.057 | 5 Hydroxytryptamine 5 antagonist | 0.055 0.045 CID_785 0.056 0.044 CID_289 | ||
| 0.034 | 0.018 | 0.04 | Cholesterol ester transfer protein antagonist | 0.036 0.017 CID_785 0.04 0.013 CID_289 | CID_289 | |
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | 0.029 0.014 CID_785 0.026 0.016 CID_289 | ||
| 0.036 | 0.021 | 0.045 | Tubulin agonist | 0.039 0.017 CID_785 0.045 0.011 CID_289 | CID_289 | |
| 0.029 | 0.014 | 0.029 | Integrin alpha2beta1 antagonist | 0.029 0.014 CID_785 0.029 0.014 CID_289 | ||
| 0.052 | 0.036 | 0.052 | 5 Hydroxytryptamine 2 agonist | 0.051 0.037 CID_785 0.045 0.043 CID_289 | ||
| 0.03 | 0.015 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 CID_785 0.027 0.022 CID_289 | CID_785 | |
| 0.078 | 0.063 | 0.08 | I kappa B kinase inhibitor | 0.08 0.061 CID_785 0.08 0.061 CID_289 | CID_289 | |
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | 0.023 0.011 CID_785 0.025 0.01 CID_289 | ||
| 0.05 | 0.035 | 0.05 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 CID_785 0.049 0.036 CID_289 | ||
| 0.024 | 0.009 | 0.025 | Retinoid X beta receptor antagonist | 0.025 0.007 CID_785 0.024 0.009 CID_289 | CID_785 | |
| 0.021 | 0.007 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.005 CID_785 0.021 0.007 CID_289 | CID_785 | |
| 0.03 | 0.015 | 0.031 | Kynurenine 3 monooxygenase inhibitor | 0.031 0.015 CID_785 0.03 0.015 CID_289 | CID_785 | |
| 0.107 | 0.093 | 0.124 | Acetylcholinesterase inhibitor | 0.103 0.1 CID_785 0.124 0.074 CID_289 | CID_289 | |
| 0.027 | 0.013 | 0.027 | Acid ceramidase inhibitor | 0.027 0.014 CID_785 0.026 0.016 CID_289 | ||
| 0.066 | 0.052 | 0.081 | Elastase 1 inhibitor | 0.063 0.057 CID_785 0.081 0.035 CID_289 | CID_289 | |
| 0.06 | 0.046 | 0.065 | Prostaglandin F2 alpha antagonist | 0.06 0.046 CID_785 0.065 0.039 CID_289 | CID_289 | |
| 0.113 | 0.099 | 0.141 | Interleukin 1 antagonist | 0.113 0.099 CID_785 0.141 0.065 CID_289 | CID_289 | |
| 0.047 | 0.033 | 0.047 | CC chemokine 4 receptor antagonist | 0.047 0.032 CID_785 0.047 0.032 CID_289 | ||
| 0.04 | 0.026 | 0.04 | Histone deacetylase 9 inhibitor | 0.039 0.027 CID_785 0.038 0.028 CID_289 | ||
| 0.042 | 0.029 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | 0.043 0.027 CID_785 0.04 0.032 CID_289 | CID_785 | |
| 0.02 | 0.007 | 0.021 | Purinergic P2Y1 agonist | 0.021 0.006 CID_785 0.02 0.007 CID_289 | CID_785 | |
| 0.021 | 0.008 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 CID_785 0.021 0.008 CID_289 | CID_785 | |
| 0.021 | 0.008 | 0.024 | Carbonic anhydrase X inhibitor | 0.024 0.006 CID_785 0.021 0.008 CID_289 | CID_785 | |
| 0.054 | 0.041 | 0.057 | Cyclin B2 inhibitor | 0.057 0.037 CID_785 | CID_785 | |
| 0.032 | 0.019 | 0.034 | AMPA 1 receptor antagonist | 0.034 0.018 CID_785 | CID_785 | |
| 0.051 | 0.038 | 0.052 | Matrix metalloproteinase 1 inhibitor | 0.051 0.038 CID_785 0.052 0.037 CID_289 | CID_289 | |
| 0.055 | 0.043 | 0.055 | Dopamine uptake inhibitor | 0.053 0.045 CID_785 0.051 0.048 CID_289 | ||
| 0.017 | 0.005 | 0.018 | Egl nine homolog 3 inhibitor | 0.018 0.005 CID_785 0.015 0.005 CID_289 | CID_785 | |
| 0.021 | 0.01 | 0.021 | Cyclin T1 inhibitor | 0.021 0.01 CID_785 0.019 0.012 CID_289 | ||
| 0.063 | 0.051 | 0.064 | Matrix metalloproteinase inhibitor | 0.063 0.051 CID_785 0.064 0.049 CID_289 | CID_289 | |
| 0.075 | 0.064 | 0.077 | Acetylcholine nicotinic agonist | 0.077 0.061 CID_785 | CID_785 | |
| 0.017 | 0.006 | 0.018 | Antibiotic Tetracycline-like | 0.018 0.005 CID_785 0.017 0.006 CID_289 | CID_785 | |
| 0.019 | 0.008 | 0.023 | Thyroid hormone alpha agonist | 0.022 0.005 CID_785 0.023 0.005 CID_289 | CID_289 | |
| 0.018 | 0.007 | 0.018 | Egl nine homolog 1 inhibitor | 0.018 0.006 CID_785 0.017 0.008 CID_289 | ||
| 0.034 | 0.023 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.023 CID_785 0.032 0.027 CID_289 | ||
| 0.04 | 0.029 | 0.044 | Toll-Like receptor 2 agonist | 0.044 0.027 CID_785 0.04 0.029 CID_289 | CID_785 | |
| 0.035 | 0.025 | 0.036 | Progesterone antagonist | 0.036 0.024 CID_785 0.034 0.026 CID_289 | CID_785 | |
| 0.025 | 0.014 | 0.025 | Prostaglandin E2 agonist | 0.025 0.014 CID_785 0.023 0.017 CID_289 | ||
| 0.082 | 0.072 | 0.083 | Pim-3 kinase inhibitor | 0.083 0.071 CID_785 | CID_785 | |
| 0.057 | 0.047 | 0.057 | Acetylcholine M2 receptor antagonist | 0.057 0.048 CID_785 | ||
| 0.043 | 0.033 | 0.044 | Sphingosine 1-phosphate receptor agonist | 0.044 0.032 CID_785 0.04 0.037 CID_289 | CID_785 | |
| 0.034 | 0.024 | 0.034 | Carnitine palmitoyltransferase inhibitor | 0.034 0.024 CID_785 0.031 0.028 CID_289 | ||
| 0.017 | 0.007 | 0.018 | Lysophosphatidic acid receptor 3 agonist | 0.018 0.006 CID_785 0.017 0.007 CID_289 | CID_785 | |
| 0.034 | 0.024 | 0.034 | Angiotensin II receptor antagonist | 0.033 0.026 CID_785 | ||
| 0.05 | 0.041 | 0.05 | GABA A receptor antagonist | 0.048 0.044 CID_785 | ||
| 0.021 | 0.012 | 0.022 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.022 0.012 CID_785 0.019 0.014 CID_289 | CID_785 | |
| 0.046 | 0.037 | 0.046 | Benzodiazepine antagonist | 0.045 0.04 CID_785 0.046 0.036 CID_289 | ||
| 0.056 | 0.047 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.047 CID_785 | ||
| 0.027 | 0.019 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 CID_785 0.026 0.021 CID_289 | ||
| 0.023 | 0.014 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 CID_785 0.026 0.011 CID_289 | CID_289 | |
| 0.083 | 0.075 | 0.086 | Polo-like kinase-1 inhibitor | 0.086 0.071 CID_785 0.086 0.07 CID_289 | CID_289 | |
| 0.022 | 0.014 | 0.027 | Estrone sulfatase inhibitor | 0.027 0.012 CID_785 | CID_785 | |
| 0.019 | 0.012 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.019 0.013 CID_785 0.021 0.01 CID_289 | CID_289 | |
| 0.013 | 0.005 | 0.013 | Thromboxane agonist | 0.013 0.005 CID_785 0.013 0.005 CID_289 | ||
| 0.012 | 0.004 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 CID_785 0.012 0.004 CID_289 | CID_785 | |
| 0.046 | 0.039 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.037 CID_785 0.048 0.035 CID_289 | CID_289 | |
| 0.012 | 0.005 | 0.012 | Progesterone receptor A antagonist | 0.012 0.005 CID_785 0.012 0.005 CID_289 | ||
| 0.041 | 0.034 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.033 CID_785 | ||
| 0.022 | 0.015 | 0.022 | Protease (Human cytomegalovirus) inhibitor | 0.022 0.015 CID_785 0.02 0.019 CID_289 | ||
| 0.01 | 0.004 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_785 0.01 0.004 CID_289 | ||
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 CID_785 0.016 0.012 CID_289 | ||
| 0.029 | 0.022 | 0.03 | Peptide deformylase inhibitor | 0.03 0.022 CID_785 0.029 0.023 CID_289 | CID_785 | |
| 0.245 | 0.239 | 0.272 | MAP kinase 1 inhibitor | 0.272 0.211 CID_289 | CID_289 | |
| 0.034 | 0.027 | 0.035 | Adenosine uptake inhibitor | 0.035 0.024 CID_785 0.034 0.027 CID_289 | CID_785 | |
| 0.016 | 0.01 | 0.017 | Adenosine A2a receptor agonist | 0.017 0.009 CID_785 0.015 0.011 CID_289 | CID_785 | |
| 0.038 | 0.032 | 0.044 | Histone deacetylase 8 inhibitor | 0.037 0.033 CID_785 0.044 0.026 CID_289 | CID_289 | |
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | 0.02 0.014 CID_785 0.019 0.015 CID_289 | ||
| 0.043 | 0.037 | 0.047 | Antimetabolite | 0.047 0.033 CID_785 0.046 0.035 CID_289 | CID_785 | |
| 0.036 | 0.03 | 0.042 | TRPM8 blocker | 0.034 0.032 CID_785 0.042 0.022 CID_289 | CID_289 | |
| 0.04 | 0.034 | 0.04 | Leukocyte elastase inhibitor | 0.039 0.035 CID_785 0.04 0.034 CID_289 | ||
| 0.015 | 0.009 | 0.016 | Integrin beta6 antagonist | 0.016 0.007 CID_785 | CID_785 | |
| 0.019 | 0.014 | 0.021 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.021 0.013 CID_785 0.018 0.015 CID_289 | CID_785 | |
| 0.015 | 0.01 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.009 CID_785 0.014 0.013 CID_289 | CID_785 | |
| 0.027 | 0.022 | 0.028 | CDK4/cyclin D3 inhibitor | 0.027 0.022 CID_785 0.028 0.021 CID_289 | CID_289 | |
| 0.039 | 0.034 | 0.039 | Plasmepsin II inhibitor | 0.038 0.034 CID_785 0.038 0.036 CID_289 | ||
| 0.022 | 0.017 | 0.022 | CYP24 inhibitor | 0.021 0.018 CID_785 | ||
| 0.026 | 0.021 | 0.036 | Leukotriene B4 receptor 1 antagonist | 0.027 0.02 CID_785 0.036 0.014 CID_289 | CID_289 | |
| 0.055 | 0.05 | 0.056 | Adenosine A2a receptor antagonist | 0.056 0.049 CID_785 | CID_785 | |
| 0.027 | 0.023 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 CID_785 | ||
| 0.079 | 0.075 | 0.079 | Hematopoietic | 0.079 0.077 CID_785 | ||
| 0.034 | 0.029 | 0.034 | Histone deacetylase 7 inhibitor | 0.033 0.03 CID_785 0.033 0.03 CID_289 | ||
| 0.019 | 0.014 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.013 CID_785 | ||
| 0.018 | 0.013 | 0.018 | Complement factor D inhibitor | 0.018 0.014 CID_785 | ||
| 0.034 | 0.03 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.026 CID_785 0.034 0.03 CID_289 | CID_785 | |
| 0.035 | 0.031 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.03 CID_785 0.038 0.024 CID_289 | CID_289 | |
| 0.007 | 0.003 | 0.008 | Transcortin receptor antagonist | 0.008 0.003 CID_785 0.006 0.004 CID_289 | CID_785 | |
| 0.016 | 0.012 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 CID_785 0.015 0.014 CID_289 | CID_785 | |
| 0.031 | 0.027 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.025 CID_785 | CID_785 | |
| 0.011 | 0.008 | 0.011 | Imidazoline I2 receptor antagonist | 0.01 0.009 CID_785 0.011 0.008 CID_289 | ||
| 0.026 | 0.023 | 0.027 | LFA antagonist | 0.026 0.022 CID_785 0.027 0.021 CID_289 | CID_289 | |
| 0.017 | 0.014 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 CID_785 | ||
| 0.047 | 0.044 | 0.047 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.044 CID_785 | ||
| 0.035 | 0.032 | 0.037 | Glutamate (mGluR group II) antagonist | 0.037 0.029 CID_785 | CID_785 | |
| 0.011 | 0.009 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 CID_785 0.011 0.01 CID_289 | CID_785 | |
| 0.01 | 0.008 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.007 CID_785 0.01 0.008 CID_289 | ||
| 0.026 | 0.024 | 0.029 | Glucagon receptor antagonist | 0.029 0.021 CID_785 0.027 0.023 CID_289 | CID_785 | |
| 0.006 | 0.004 | 0.017 | Insulin like growth factor 3 antagonist | 0.007 0.004 CID_785 0.017 0.002 CID_289 | CID_289 | |
| 0.013 | 0.011 | 0.013 | Prostaglandin EP4 agonist | 0.013 0.012 CID_785 | ||
| 0.023 | 0.021 | 0.023 | Sigma 2 receptor antagonist | |||
| 0.049 | 0.047 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | 0.049 0.047 CID_785 0.051 0.045 CID_289 | CID_289 | |
| 0.007 | 0.005 | 0.007 | Integrin alpha5beta6 antagonist | 0.006 0.005 CID_785 0.006 0.005 CID_289 | ||
| 0.018 | 0.017 | 0.019 | Kainate receptor 1 antagonist | 0.019 0.016 CID_785 | CID_785 | |
| 0.013 | 0.011 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 CID_785 0.013 0.01 CID_289 | ||
| 0.028 | 0.027 | 0.028 | Epoxide hydrolase 1 inhibitor | 0.028 0.027 CID_785 0.028 0.027 CID_289 | ||
| 0.053 | 0.052 | 0.054 | Collagenase 3 inhibitor | 0.054 0.05 CID_785 | CID_785 | |
| 0.041 | 0.04 | 0.041 | Glutamate (mGluR5) agonist | |||
| 0.084 | 0.084 | 0.086 | Cyclin-dependent kinase 9 inhibitor | 0.085 0.083 CID_785 0.086 0.082 CID_289 | CID_289 | |
| 0.015 | 0.015 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 CID_785 | CID_785 | |
| 0.015 | 0.015 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 CID_785 | CID_785 | |
| 0.011 | 0.011 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.009 CID_785 | CID_785 | |
| 0.041 | 0.041 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.045 0.033 CID_785 0.046 0.03 CID_289 | CID_289 | |
| 0.063 | 0.064 | 0.064 | Calcium channel L-type blocker | 0.064 0.061 CID_289 | CID_289 | |
| 0.026 | 0.029 | 0.027 | MAP3K8 inhibitor | 0.027 0.026 CID_785 | CID_785 | |
| 0.052 | 0.055 | 0.056 | Cyclin B1 inhibitor | 0.056 0.049 CID_785 | CID_785 | |
| 0.045 | 0.049 | 0.05 | Alpha 1b adrenoreceptor agonist | 0.05 0.036 CID_289 | CID_289 | |
| 0.047 | 0.052 | 0.05 | Cyclin B inhibitor | 0.05 0.046 CID_785 | CID_785 | |
| 0.032 | 0.037 | 0.036 | Dopamine D3 agonist | 0.036 0.032 CID_289 | CID_289 | |
| 0.047 | 0.052 | 0.05 | Glutamate (mGluR1) antagonist | 0.05 0.048 CID_785 | CID_785 | |
| 0.108 | 0.117 | 0.148 | Neurotrophic factor | 0.113 0.108 CID_785 0.148 0.061 CID_289 | CID_289 | |
| 0.035 | 0.046 | 0.043 | Phosphodiesterase 3B inhibitor | 0.043 0.033 CID_785 | CID_785 | |
| 0.027 | 0.044 | 0.031 | Vanilloid 4 antagonist | 0.031 0.027 CID_289 | CID_289 | |
| 0.024 | 0.047 | 0.034 | Cathepsin L2 inhibitor | 0.034 0.033 CID_289 | CID_289 | |
| 0.099 | 0.123 | 0.11 | CDC-like kinase 1 inhibitor | 0.11 0.106 CID_785 | CID_785 | |
| 0.14 | 0.164 | 0.155 | Growth factor agonist | 0.155 0.131 CID_289 | CID_289 | |
| 0.047 | 0.078 | 0.075 | Transcription factor AP-1 inhibitor | 0.075 0.025 CID_289 | CID_289 | |
| 0.049 | 0.091 | 0.078 | Bcl-xL inhibitor | 0.078 0.013 CID_289 | CID_289 | |
| 0.059 | 0.102 | 0.085 | Antiadrenergic | 0.085 0.067 CID_289 | CID_289 | |
| 0.014 | 0.057 | 0.018 | Granulocyte colony stimulating factor receptor agonist | 0.018 0.013 CID_289 | CID_289 | |
| 0.049 | 0.095 | 0.115 | Telomerase inhibitor | 0.115 0.028 CID_289 | CID_289 | |
| 0.056 | 0.101 | 0.082 | Adrenaline antagonist | 0.082 0.067 CID_289 | CID_289 | |
| 0.111 | 0.161 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.149 0.121 CID_289 | CID_289 | |
| 0.083 | 0.143 | 0.155 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.155 0.074 CID_289 | CID_289 | |
| 0.112 | 0.191 | 0.143 | Death-associated protein kinase 3 inhibitor | 0.143 0.133 CID_289 | CID_289 | |
| 0.117 | 0.212 | 0.144 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.144 0.143 CID_289 | CID_289 | |
| 0.03 | 0.131 | 0.084 | HIV-1 reverse transcriptase inhibitor | 0.084 0.039 CID_289 | CID_289 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |